{
    "componentChunkName": "component---src-templates-article-page-js",
    "path": "/journals/biology/micropub-biology-002268",
    "result": {"data":{"article":{"manuscript":{"id":"578fcdb4-5134-445e-8a62-7adf5dfbe939","submissionTypes":["methodology","new finding"],"citations":[],"doi":"10.17912/micropub.biology.002268","dbReferenceId":null,"pmcId":null,"pmId":null,"proteopedia":null,"reviewPanel":null,"species":["human","escherichia coli"],"integrations":[],"corrections":null,"history":{"received":"2026-07-05T06:57:24.124Z","revisionReceived":"2026-10-25T07:33:50.115Z","accepted":"2026-11-18T23:10:45.947Z","published":"2026-11-19T17:26:08.213Z","indexed":"2026-12-03T17:26:08.213Z"},"versions":[{"id":"8ce45bd8-1b8a-48f7-8cb0-aca4941050df","decision":"revise","abstract":"<p>The human proteome holds immense potential, yet many \"dark\" proteins remain functionally uncharacterized. Here, we apply the Bacterial Growth Inhibition Screen (BGIS)—previously validated on the DEK oncoprotein—to 29 dark human proteins. Through a three-phase screening pipeline comprising initial bacterial toxicity assessment, AlphaFold-guided domain mapping, and error-prone PCR mutagenesis, BGIS successfully identified functional domains in 8 of 29 dark proteins, and, as expemlified by PBDC1, successfully generated loss-of-function (LoF) mutants. This proof-of-concept study establishes BGIS as a scalable, cost-effective framework for active domain identification and LoF tool generation, providing a novel experimental entry point for dark proteome research.</p>","acknowledgements":"","authors":[{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":[""],"credit":["conceptualization","dataCuration","formalAnalysis","fundingAcquisition","investigation","methodology","validation","visualization","writing_originalDraft","writing_reviewEditing"],"email":"songhe.jin@dukekunshan.edu.cn","firstName":"Songhe ","lastName":"Jin","submittingAuthor":false,"correspondingAuthor":false,"equalContribution":false,"WBId":null,"orcid":null},{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":[""],"credit":["conceptualization","dataCuration","formalAnalysis","fundingAcquisition","investigation","methodology","validation","writing_originalDraft","writing_reviewEditing"],"email":"chutian.chen@duke.edu","firstName":"Chutian ","lastName":"Chen ","submittingAuthor":false,"correspondingAuthor":false,"equalContribution":false,"WBId":null,"orcid":null},{"affiliations":["Xi'an Jiaotong-Liverpool University "],"departments":["Department of Biosciences and Bioinformatics"],"credit":["conceptualization","supervision","visualization","methodology"],"email":"yewei.liu@dukekunshan.edu.cn","firstName":"Yewei ","lastName":"Liu ","submittingAuthor":false,"correspondingAuthor":true,"equalContribution":true,"WBId":null,"orcid":"0009-0006-5666-1977"},{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":["Division of Natural and Applied Sciences"],"credit":["conceptualization","fundingAcquisition","supervision","resources","writing_reviewEditing"],"email":"Ferdinand.Kappes@dukekunshan.edu.cn","firstName":"Ferdinand","lastName":"Kappes","submittingAuthor":true,"correspondingAuthor":true,"equalContribution":true,"WBId":null,"orcid":"0000-0002-0369-0065"}],"awards":[],"conflictsOfInterest":"<p>The authors declare that there are no conflicts of interest present.</p>","dataTable":{"url":null},"extendedData":[{"description":"<p>Extended Data 1. Images of BGIS experiments supporting the screening results shown in Fig. 1B–C.</p><p>(A) Representative BGIS results of the 29 selected human dark proteins. Each protein was transformed into E. coli BL21(DE3) and plated on LB-AMP plates with (+IPTG) or without (−IPTG) IPTG induction. Growth inhibition was evaluated by comparing colony formation between induced and non-induced conditions. Among the 29 proteins screened, CAAP1, MSANTD7, and DNAJC28 exhibited complete growth inhibition, whereas PBDC1, PPAN-P2RY11, TMX3, EVA1C, and STKLD1 exhibited partial growth inhibition upon IPTG induction. &nbsp;(B) Representative BGIS results of protein fragments derived from the inhibitory proteins identified in (A). Protein fragments were generated based on AlphaFold2-predicted structural boundaries and screened using BGIS to localize domain-specific growth inhibition activity.</p>","doi":null,"resourceType":"Dataset","name":"Ex 1.jpg","url":"https://portal.micropublication.org/uploads/9739f2baa6fc8dfcac40564fd54d8817.jpg"},{"description":"<p>Extended Data 2. Validation of recombinant protein expression by Western blotting.</p><p>Whole-membrane Western blot images of the 29 GST-fusion proteins constructed in this study. Molecular weight markers (kDa) are indicated on the left of each membrane. The corresponding gene names and theoretical molecular weights are shown above each blot. Compared with the corresponding −IPTG controls, the +IPTG lanes exhibited stronger recombinant protein bands, confirming successful IPTG-induced expression of the GST-fusion proteins. For most proteins, the major immunoreactive band migrated close to the theoretical molecular weight, justifying the successful expression of the designated proteins. Multiple lower-molecular-weight bands were frequently observed beneath the major band, likely reflecting endogenous proteolytic cleavage during heterologous expression in E. coli.</p>","doi":null,"resourceType":"Dataset","name":"Ex2 (1).pdf","url":"https://portal.micropublication.org/uploads/70026a5b26cb2841667e2e73af897ae9.pdf"}],"funding":"<p>This work was supported by internal funding from Duke Kunshan University, including the Summer Research Scholarship (SRS), Signature Work Fund (SF), Signature Work Research Grant (SWRG),  a grant from the DKU Innovation Incubator (Dii), and a Start-up Fund.</p>","image":{"url":"https://portal.micropublication.org/uploads/3e41b00973c4d27129adb97ed0a42547.jpg"},"imageCaption":"<p><b>(A) General BGIS workflow. </b>Phase 1, Initial BGIS: full-length dark proteins are expressed as GST fusions in <i>E. coli</i> BL21(DE3) and growth inhibition upon IPTG induction is monitored. Phase 2, Domain specific BGIS: proteins with inhibitory functions are fragmented based on AlphaFold2-predicted structural boundaries and re-screened via BGIS in order to localize the inhibitory and thus potential functional domain(s). Phase 3, Domain -specific Loss-of-Function (LoF) mutant screen: specific inhibitory domains are subjected to random mutagenesis by error-prone PCR and re-screened via BGIS for potential LoF escape mutants. <b>(B)</b> <b>Summary table of all 29 dark proteins screened in Phase 1. </b>Detailed selection criteria of these 29 dark proteins are described in the Methods section. PubMed scores were sourced from the Pharos/TCRD database, reflecting the limited literature representation of these dark protein candidates. Proteins exhibiting complete or partial bacterial growth inhibition upon IPTG induction are highlighted in blue; non-inhibitory proteins are not highlighted. Images of BGIS experiments can be found in Extended Data 1A (one representative experiment out of three are shown for each protein).<b> (C)</b> <b>Summary of</b> <b>BGIS results for all inhibitory proteins and their fragments from Phases 1 and 2.</b> Complete inhibition (marked as \"Complete\") indicates no colony formation on +IPTG plates; partial inhibition (marked as \"Partial\") indicates significantly reduced colony size on +IPTG plates relative to −IPTG controls. Images of BGIS experiments can be found in Extended Data 1B. <b>(D-E)</b> <b>Proof-of-concept demonstration using PBDC1. (D) BGIS results of PBDC1, its fragmentations, and error-prone PCR mutagenesis.</b> Colony plate images show BGIS results for full-length PBDC1 and its AlphaFold-guided fragments (Region 1 and Region 2), where IPTG induction drives expression of the corresponding GST-fusion protein cloned into pGEX-4T-1. GST empty vector and GST-DEK fusion protein served as negative and positive controls respectively. Error-prone PCR (EP) was performed at two MnCl₂ concentrations 0.3% (w/v) (EP 0.3%) and 0.5% (w/v) (EP 0.5%), the resulting mutant libraries were transformed into <i>E. coli</i> BL21(DE3). Large colonies emerging on +IPTG plates represent escape mutants that have lost growth-inhibitory activity and were selected for sequencing. <b>(E)</b> <b>Validated Loss-of-Function (LoF) mutants in PBDC1 Region 2. </b>After excluding sequences containing indels or nonsense mutations, remaining sequences were&nbsp; filtered to retain only those harboring missense mutations, discarding synonymous substitutions. The resulting nucleotide changes and corresponding amino acid substitutions are indicated. Three validated LoF mutants were identified in PBDC1 Region 2.</p>","imageTitle":"<p>Bacterial Growth Inhibition Screen (BGIS) of 29 human dark proteins identifies functional domains and loss-of-function mutants in PBDC1</p>","methods":"<p><b>Protein Selection and Plasmid Construction</b></p><p><a>Candidate proteins were selected using the Target Development Level (TDL) classification in Pharos/TCRD </a>(Kelleher et al., 2023), focusing on proteins categorized as Tdark or low-confidence Tbio — tiers representing the least characterized fraction of the human proteome. Candidates were further filtered by two criteria: (i) the presence of at least one structurally discrete domain, as assessed by visual inspection of AlphaFold-predicted models (Jumper et al., 2021), and (ii) a Pharos PubMed Score below 50 — a conservative threshold well below well- studied and early-stage research targets (e.g., EGFR: 19,716; LRRK2: 2,119; DEK: 370) — indicating minimal direct representation in the biomedical literature <b>(Fig. 1B)</b>.</p><p><b>&nbsp;</b></p><p>Additionally, three proteins absent from the Pharos/TCRD database were included as supplementary candidates to broaden the coverage of understudied targets. A0A1W2PQ72 (MSANTD7) is a reviewed Swiss-Prot entry with a UniProt annotation score of 2/5, reflecting near-absent experimental characterization. A6NDF3 (PBDC1) is an unreviewed TrEMBL entry with an annotation score of 1/5, but notably carries \"Evidence at protein level\", confirming experimental detection while remaining entirely without functional annotation. A0A0A6YYI3 (PPAN-P2RY11) is unreviewed with an annotation score of 1/5 and protein existence classified as \"Predicted\", indicating no experimental evidence for its expression or function.</p><p>&nbsp;</p><p>Coding sequences were codon-optimized for <i>E. coli</i> BL21 (DE3) expression using the IDT Codon Optimization Tool and synthesized by GenScript. Each fragment was cloned into pGEX-4T-1 (GenScript) between the EcoRI and XhoI restriction sites, enabling IPTG-inducible expression as an N-terminal GST fusion protein. Correct insertion and sequence was confirmed by Sanger sequencing prior to use. Expression of target proteins in bacteria was verified by immunoblotting using GST-specific antibodies (see below and Extended data 2 ).</p><p><b>Bacterial Growth Inhibition Screen (BGIS)</b></p><p>LB agar was prepared at 40 g/L, autoclaved at 121 °C for 20 min, and supplemented with ampicillin (100 μg/mL) at ~50 °C. For BGIS plates, IPTG was additionally added to 0.1 mM at ~40 °C. Plates were dried in a biosafety cabinet and stored at 4 °C until use.</p><p>All plasmids were diluted to 10 ng/μL in nuclease-free water. Chemically competent <i>E. coli</i> BL21(DE3) cells (50 μL) were incubated with 1 μL plasmid on ice for 20 min, heat-shocked at 42 °C for 45 s, returned to ice for 5 min, and recovered in 70 μL LB for 5 min. Equal volumes (50 μL) of transformed culture were spread onto paired LB-AMP plates with and without 0.1 mM IPTG and incubated at 37 °C overnight. Colony formation was compared between conditions and proteins were classified as causing \"complete inhibition,\" \"partial inhibition,\" or \"no inhibition.\" The empty pGEX-4T-1 vector (GST alone) served as the negative control; a GST-DEK fusion protein served as the positive control (Guo et al., 2021). All BGIS analyses were carried out in triplicate, and the results were reproducible across all replicates.</p><p><b>Protein Expression and Western Blotting</b></p><p>Single colonies were inoculated into 5 mL LB-AMP and grown overnight at 37 °C. The following day, 1 mL of overnight culture was diluted into 4 mL LB-AMP and incubated at 37 °C for 2 h. The culture was divided into two 1.5 mL aliquots; one was supplemented with 0.1 mM IPTG and both were incubated for a further 1.5 h at 37 °C.</p><p>Cells were pelleted at 8,000 rpm (6,080 × g) for 1 min, resuspended in 100 μL 2% SDS, 40% power ultrasonic disrupted (SCIENTZ Ultrasonic Homogenizer JY96-IIN) for 3-5 seconds until the solution lost its viscosity. 12 μL of lysate was combined with 3 μL 5× Laemmli Sample buffer, heated at 95 °C for 5 min, and resolved by SDS-PAGE on 10% polyacrylamide gels at 80 V (stacking) then 120 V (resolving). Proteins were transferred to PVDF membrane by semi-dry transfer at 100 mA for 75 min. After blocking with 5% skim milk in TBST, membranes were probed overnight at 4 °C with an anti-GST rabbit monoclonal antibody (1:1,000; Beyotime), washed three times in TBST, then incubated with HRP-conjugated goat anti-rabbit IgG (1:10,000; Beyotime) for 60 min at room temperature. Signal was detected by chemiluminescence (Cytiva, ImageQuant 800).</p><p><b>AlphaFold-Guided Protein Fragmentation and Subcloning</b></p><p>Proteins with inhibitory phenotypes were fragmented for domain-level mapping. Boundaries were determined from AlphaFold2-predicted structures and per-residue confidence (pLDDT) scores (https://alphafold.ebi.ac.uk/): domain interfaces were used where clear tertiary boundaries existed, and transitions from low (yellow) to very low (orange) pLDDT were used otherwise. Fragments were designed to span 80–200 amino acids.</p><p>Primers were designed with target T<sub>m</sub> of 51–56 °C and GC content of 40–60%, adding restriction enzyme cleavage site,and verified by BLAST against the constructed full length protein’s plasmid sequence. PCR was performed in 50 μL reaction system (Reagent Table 3) with the following cycling conditions: 95 °C for 3 min; 33 cycles of 95 °C for 30 s, 56 °C for 30 s, 72 °C for 1min; final extension at 72 °C for 5 min; hold at 12 °C. Products were resolved on 1% agarose gels containing Gel Red Nucleic Acid (Adamas Life) at 120 V for 30 min, and bands of correct size were excised and purified using the QIAGEN QIAquick Gel Extraction Kit (eluted in 30 μL nuclease-free water).</p><p>&nbsp;</p><p>Gel-purified fragments and the pGEX-4T-1 vector were digested with EcoRI and XhoI (Reagent Table 4). For inserts containing an internal EcoRI site (e.g., protein 159), SalI was substituted for EcoRI. Digested products were column-purified prior to ligation. Ligation was carried out in a 20 μL reaction containing insertion sequence and linearized vector at a 3:1 molar ratio, 1× T4 DNA Ligase buffer, and T4 DNA Ligase (Beyotime) (Reagent Table 5), incubated at 25 °C for 2 h or 16 °C overnight. 10 μL of ligation product was transformed into DH5α competent cells using the same heat-shock protocol described above and plated on LB-AMP agar. Colonies were screened by Sanger sequencing (Sangon Biotech, Suzhou), and verified constructs were propagated in DH5α, extracted by miniprep (QI Aprep Spin Miniprep Kit), and retransformed into BL21(DE3) for secondary BGIS.</p><p><b>Error-Prone PCR Mutagenesis</b></p><p>To generate loss-of-function (LoF) mutants libraries, error-prone PCR was applied to the coding sequence of each inhibitory domain to generate random mutations. Two MnCl<sub>2</sub> concentrations were used to modulate mutation frequency (Reagent Table 6); all other conditions were identical to the standard PCR. Amplified mutant mixtures were gel-purified, digested, ligated into pGEX-4T-1, and transformed into BL21(DE3) as described above. Transformants were plated on LB-AMP-IPTG plates and incubated overnight at 37 °C.</p><p>Because all selected proteins either completely or partially inhibit <i>E. coli</i> growth upon induction, colonies with loss-of-function (LoF) mutated genes on +IPTG plates were visibly larger than background microcolonies, indicative of a mutation that abolishes the growth-inhibitory activity of the expressed protein. They were designated as candidate LoF mutants.</p><p><b><a>Sanger Sequencing and Loss-of-Function Mutant Identification</a></b></p><p>Large colonies from +IPTG plates were picked and their plasmids extracted for Sanger sequencing (Sangon Biotech, Suzhou). Sequences were aligned to the wild-type reference using SnapGene to identify all nucleotide changes relative to the wild-type coding sequence.</p><p>Candidate sequences were then filtered using the following criteria to isolate biologically informative LoF mutations. First, sequences containing any insertion or deletion were excluded, as frameshift mutations globally disrupt protein structure and preclude interpretation of specific functional residues. Second, sequences harboring premature stop codons (nonsense mutations) were excluded for the same reason—truncated proteins cannot be used to reliably attribute loss of function to a specific domain or residue. Third, synonymous substitutions—single-nucleotide changes that do not alter the encoded amino acid (silent mutations)—were also excluded, as they are unlikely to contribute to the observed loss of the growth-inhibitory phenotype. Only sequences carrying non-synonymous single-nucleotide substitutions (missense mutations) were retained for LoF mutants libraries.</p><p></p>","reagents":"<p>Table 1. Bacterial Strains</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Strains</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p><i>E. coli</i> BL21(DE3)pLysS</p></td><td><p>AngyuBio</p></td></tr><tr><td><p><i>E. coli</i> DH5α</p></td><td><p>AngyuBio</p></td></tr></tbody></table><p></p><p>Table 2. Plasmids</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Plasmids</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p>pGEX-4T-1</p></td><td><p>Genescript</p></td></tr></tbody></table><p></p><p>Table 3. PCR reaction system (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Final Concentration</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>to 50</p></td><td><p>—</p></td></tr><tr><td><p>10× BeyoTaq Buffer with Mg<sup>2+</sup> (Beyotime, #D7020-2)</p></td><td><p>5</p></td><td><p>1×</p></td></tr><tr><td><p>dNTP mixture (25mM) (Beyotime, #D7371 )</p></td><td><p>0.4</p></td><td><p>0.2 mM</p></td></tr><tr><td><p>Primer Forward (10 μM)</p></td><td><p>2</p></td><td><p>0.4 μM</p></td></tr><tr><td><p>Primer Reverse (10 μM)</p></td><td><p>2</p></td><td><p>0.4 μM</p></td></tr><tr><td><p>Template plasmid</p></td><td><p>—</p></td><td><p>[20 ng]</p></td></tr><tr><td><p>Beyo Taq DNA polymerase (5U/μL) (Beyotime, #D7219-1)</p></td><td><p>0.25</p></td><td><p>[1.25 U]</p></td></tr></tbody></table><p></p><p>Table 4. Restriction endonuclease digestion system (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>to 50</p></td></tr><tr><td><p>10× CutSmart buffer (New England Biolabs, #B6004S)</p></td><td><p>5</p></td></tr><tr><td><p>PCR product or vector</p></td><td><p>30</p></td></tr><tr><td><p>Restriction endonuclease</p><p>(XhoI: NEB, #R0146V; EcoRI: NEB, #R3101V)</p></td><td><p>1 each</p></td></tr></tbody></table><p></p><p>Table 5. T4 Ligation System.</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td></tr><tr><td><p>T4 DNA Ligase Buffer (NEB, #B0202S)</p></td><td><p>2</p></td></tr><tr><td><p>T4 DNA Ligase (Beyotime, #D7006-1)</p></td><td><p>0.5</p></td></tr><tr><td><p>Digested DNA Fragment (~30ng/μL)</p></td><td><p>2</p></td></tr><tr><td><p>Digested linear pGEX-4T-1 (~5ng/μL)</p></td><td><p>16</p></td></tr></tbody></table><p></p><p>Table 6. Error-prone PCR reaction systems (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>0.3 % (w/v) MnCl₂ System (μL)</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>0.5 % (w/v) MnCl₂ System (μL)</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>Up to 50</p></td><td><p>Up to 50</p></td></tr><tr><td><p>10× BeyoTaq Buffer with Mg<sup>2+</sup> (Beyotime, #D7020-2)</p></td><td><p>5</p></td><td><p>5</p></td></tr><tr><td><p>dNTP mixture (25mM) (Beyotime, #D7371 )</p></td><td><p>4</p></td><td><p>4</p></td></tr><tr><td><p>Template</p></td><td><p>1</p></td><td><p>1</p></td></tr><tr><td><p>Forward primer (10 μM)</p></td><td><p>2</p></td><td><p>2</p></td></tr><tr><td><p>Reverse primer (10 μM)</p></td><td><p>2</p></td><td><p>2</p></td></tr><tr><td><p>Beyo Taq DNA polymerase (5U/μL) (Beyotime, #D7219-1)</p></td><td><p>0.25</p></td><td><p>0.25</p></td></tr><tr><td><p>MnCl₂ 10% (w/v) stock</p></td><td><p>1.5</p></td><td><p>2.5</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 7: Protein fragmentation primers</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Primer_name</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Primer_seq</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p>Common_F</p></td><td><p>CAAAATCGGATCTGGTTCCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>Common_R</p></td><td><p>TCGTCAGTCAGTCACGATG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-1_R</p></td><td><p>TCACTCGAGCTCCAAGTCGCTGTGTTC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-2_F</p></td><td><p>TCAGAATTCGACTTGGAGGAAGGTGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-2_R</p></td><td><p>TCACTCGAGCTCCTCCATGTCCGAATCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-3_F</p></td><td><p>TCAGAATTCGAGGAGGAAGCGGATGATG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>DNAJC28-1_R</p></td><td><p>ACTCTCGAGTCACCTTTAGCCATGCTCTCCT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>DNAJC28-2_F</p></td><td><p>TCAGAATTCGGTGATTTCGATAACCTCTCCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-1_R</p></td><td><p>TCTCTCGAGTCTTCAGTTCATTCGGCTGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-2_F</p></td><td><p>TCAGAATTCGTGTCTTTTAAGTGCCAGCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-2_R</p></td><td><p>TCACTCGAGCGGCTTCAGGTTGGC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-3_F</p></td><td><p>TCAGAATTCGCGATCGCCAACCTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>MSANTD7-1_R</p></td><td><p>ACACTCGAGGCAACCAAGTTTTGATCGCAG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>MSANTD7-2_F</p></td><td><p>TCAGAATTCCACTGCGATCAAAACTTGGTT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PPAN-P2RY11-1_R</p></td><td><p>TCACTCGAGCTCTTCCTCAGTTTTGC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PPAN-P2RY11-2_F</p></td><td><p>TCAGAATTCGGCAAAGTGATGTTTCACTCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>STKLD1-1_R</p></td><td><p>ACTCTCGAGCTGCCTCTCAGGAAGGTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>STKLD1-2_F</p></td><td><p>TCAGAATTCGGCAGTTTCAAGTCCAGTTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-1_R</p></td><td><p>ACACTCGAGGAAGTGGCCGAATTAGAG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-2_F</p></td><td><p>ACAGAATTCCCACTTCCAAGTCAACAAATGT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-2_R</p></td><td><p>ACACTCGAGAAACCTTTCCCTGTTGATCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-3_F</p></td><td><p>TCAGAATTCCAGAATTACCTTGCTATGGATGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PBDC1-1_R</p></td><td><p>TCACTCGAGCGTTTCTTCTCAACGGTC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PBDC1-2_F</p></td><td><p>TCAGAATTCGTTGAGAAGAAACGTACCC</p></td><td><p>Sangon Biotech</p></td></tr></tbody></table><p>&nbsp;</p>","patternDescription":"<p>Despite the Human Genome Project's identification of ~20,000 protein-coding genes (Nurk et al., 2022) and large-scale efforts such as the HUPO Human Proteome Project (Omenn et al., 2024), a substantial portion of the human proteome remains functionally unannotated — the so-called \"dark proteins\" — whose activities and interactions have yet to be experimentally elucidated (Cao et al., 2024).</p><p>&nbsp;While recent studies highlighted that many dark proteins indeed execute essential functions in organisms (Moitra &amp; Larrouy-Maumus, 2026; Rocha et al., 2023),<a> research on dark proteins remains limited often due to lack of molecular tools and the labor-intensive nature with uncertain rewards</a> (Sharifi Tabar et al., 2022). In addition, despite structural predictions by Alphfold (Jumper et al., 2021), deciphering experimentally molecular functions at the domain level in dark proteins presents a methodological challenge. A further critical step in such studies is the generation of <b>Loss-of-Function (LoF) mutants, </b>which allow researchers to causally link a specific protein activity to a cellular phenotype, rather than relying solely on gene-level knockdown or knockout approaches that abolish all protein functions simultaneously (Guo, Prell, et al., 2021). Conventional site-directed mutagenesis is the standard strategy for generating such mutants; however, it requires detailed prior knowledge of protein structure and functionally important residues (Brannigan &amp; Wilkinson, 2002). For dark proteins, this information is typically not readily available.</p><p>&nbsp;Therefore, for dark proteins lacking any such prior information, an unbiased, hypothesis-independent approach to functional domain identification and LoF mutant generation is required.<a> To address this challenge, Guo et al. (2021) established the Bacterial Growth Inhibition Screen (BGIS) for the study of proteins.</a> Using this strategy, we successfully identified an RNA binding domain and created LoF DNA binding mutants in the DEK oncoprotein. Together, these results demonstrated that BGIS has the capacity to identify functional daomains and to pinpoint critical residues in a fully hypothesis-independent manner (Guo, Prell, et al., 2021; Guo, Xu, et al., 2021).</p><p>However, BGIS has only been validated on the DEK protein with known functions, and its applicability to dark proteins — where no functional or structural reference exist — remains unexplored. One barrier lies in domain fragmentation: localizing the inhibitory activity to a specific region of a full-length protein requires rational boundaries for fragmentation—information that is unavailable for dark proteins. The release of AlphaFold2, which provides high-confidence structural predictions for protein sequences, offers a solution to this problem by enabling structure-guided fragmentation without experimental structural data. In this study, we therefore integrate BGIS with AlphaFold2-predicted domain boundaries to systematically screen human dark proteins for growth-inhibitory activity, localize functional domains, and generate LoF mutants — establishing a proof-of-concept workflow for hypothesis-independent functional annotation of the dark proteome.</p><p>&nbsp;To test this, we selected and screened 29 human dark proteins through a three-phase BGIS pipeline <b>(Fig. 1A)</b>. In Phase 1, each selected protein was expressed as a GST fusion in <i>E. coli</i> BL21(DE3) and assessed for growth inhibition upon IPTG induction, using GST alone as a negative control and the DEK oncoprotein as a positive control (Guo, Prell, et al., 2021). Growth inhibition was defined as either complete absence or substantial reduction of colony formation or colony size on IPTG-containing plates relative to non-inducing controls <b>(Fig. 1D; <a>Extended Data 1 A</a> and B)</b>. Proteins exhibiting growth inhibition, thus containing a growth inhibitory function, were carried into Phase 2, where AlphaFold2-predicted structural boundaries guided the design of protein fragments <b>(Fig. 1D)</b>, allowing the inhibitory activity to be localized to a defined domain without relying on experimental structural data. In Phase 3, the inhibitory domain was subjected to error-prone PCR mutagenesis to generate random variant libraries. Colonies that escaped growth inhibition were then selected as candidate loss-of-function mutants, with confirmed missense mutations identified by sequencing.</p><p>&nbsp;<a>Of the 29 dark proteins screened in Phase 1, 8 exhibited complete or partial growth inhibition upon IPTG induction </a><b><a>(Fig. 1B; highlighted in blue; Extended Data 1A)</a></b><a>, indicating that while BGIS is not universally applicable, a meaningful fraction of dark proteins possesses activity detectable by this approach. In Phase 2, AlphaFold2-guided fragmentation successfully localized the inhibitory activity to a defined domain in 5 of these proteins </a><b><a>(Fig. 1C; Extended Data 1B)</a></b><a>, validating the utility of structure-predicted boundaries as a fragmentation strategy</a>. To demonstrate the complete three-phase workflow, PBDC1 was taken to Phase 3 as a proof-of-concept example <b>(Fig. 1D–1E)</b>. Phase 2 fragmentation revealed that both region 1 and region 2 of PBDC1 independently exhibited growth-inhibitory activity, with region 1 producing complete inhibition and region 2 producing partial inhibition <b>(Fig. 1D)</b>. Error-prone PCR mutagenesis was performed on both regions; however, only region 2 yielded validated LoF mutants after sequencing-based filtering excluding nonsense and frameshift variants. Three missense mutants were identified in region 2, each carrying 2-3 amino acid substitutions, providing experimental evidence for potential functionally critical residues within PBDC1 <b>(Fig. 1E).</b></p><p>&nbsp;Together, the screening of 29 human dark proteins, including domain-level activity localization for 6 of them, offers a preliminary reference that may serve as an entry point for future investigations into these uncharacterized proteins. For PBDC1 specifically, Phase 2 fragmentation and Phase 3 mutagenesis further yielded three validated LoF mutants in region 2, identifying potentially critical residues and providing tools for future mechanistic investigation. Moreover, the successful application of BGIS to human dark proteins serves as a proof-of-concept of a fast, low-cost workflow that requires no prior functional assumptions. While not universally applicable, this approach offers a practical methodology for researchers encountering bottlenecks in the functional characterization and LoF tool generation of uncharacterized proteins.</p><p>&nbsp;Several caveats and weaknesses shall be noted. First, the mechanism underlying growth inhibition has not been experimentally verified for each dark protein screened; unlike DEK, whose toxicity was linked to direct DNA compaction (Guo, Prell, et al., 2021). Thus, the molecular basis of inhibition in other candidates remains unknown, and growth inhibition alone cannot be taken as evidence of its molecular activity in the eukaryotic context. Second, the AlphaFold2-guided fragmentation strategy relies on empirical identification of structural boundaries based on the visual clustering of secondary structure elements, which is subjective and may not reflect true functional domain boundaries. The reliability of this approach is further constrained by regional variations in AlphaFold2 prediction confidence (pLDDT scores), particularly in intrinsically disordered regions where boundary assignments are less certain. Third, the screen covers 29 proteins, and conclusions regarding the broader applicability of BGIS to the dark proteome should be interpreted with caution.<a> </a>Fourth, the error-prone PCR mutagenesis condition requires further optimization. The MnCl₂ concentration — the primary determinant of mutation load — proved difficult to control in practice and single mutations were difficult to obtain. Finally, the identified LoF mutants have not been subjected to reversion mutagenesis, nor have the confirmed substitutions been reintroduced into full-length PBDC1 and re-expressed in <i>E. coli</i> to verify their effect in the intact protein context. As all validations were performed solely at the bacterial level, whether these mutations disrupt PBDC1 function in a eukaryotic context also remains to be determined. Future studies could perform reversion mutagenesis to define the minimal functional substitution set, reintroducing confirmed mutations into full-length PBDC1 for bacterial re-expression, and ultimately characterizing these proteins and their LoF mutants in human cells to get eukaryotic context information.</p>","references":[{"reference":"<p>Brannigan, J. A., &amp; Wilkinson, A. J. (2002). Protein engineering 20 years on. <i>Nature Reviews Molecular Cell Biology</i>, <i>3</i>(12), 964–970. https://doi.org/10.1038/nrm975</p>","pubmedId":"","doi":""},{"reference":"<p>Cao, X., Sun, S., &amp; Xing, J. (2024). A Massive Proteogenomic Screen Identifies Thousands of Novel Peptides From the Human “Dark” Proteome. <i>Molecular &amp; Cellular Proteomics: MCP</i>, <i>23</i>(2), 100719. https://doi.org/10.1016/j.mcpro.2024.100719</p>","pubmedId":"","doi":""},{"reference":"<p>Guo, H., Prell, M., Königs, H., Xu, N., Waldmann, T., Hermans‐Sachweh, B., Ferrando‐May, E., Lüscher, B., &amp; Kappes, F. (2021). Bacterial Growth Inhibition Screen (BGIS) identifies a loss‐of‐function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin. <i>FEBS Letters</i>, <i>595</i>(10), 1438–1453. https://doi.org/10.1002/1873-3468.14070</p>","pubmedId":"","doi":""},{"reference":"<p>Guo, H., Xu, N., Prell, M., Königs, H., Hermanns-Sachweh, B., Lüscher, B., &amp; Kappes, F. (2021). Bacterial Growth Inhibition Screen (BGIS): Harnessing recombinant protein toxicity for rapid and unbiased interrogation of protein function. <i>FEBS Letters</i>, <i>595</i>(10), 1422–1437. https://doi.org/10.1002/1873-3468.14072</p>","pubmedId":"","doi":""},{"reference":"<p>Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., Bridgland, A., Meyer, C., Kohl, S. A. A., Ballard, A. J., Cowie, A., Romera-Paredes, B., Nikolov, S., Jain, R., Adler, J., … Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. <i>Nature</i>, <i>596</i>(7873), 583–589. https://doi.org/10.1038/s41586-021-03819-2</p>","pubmedId":"","doi":""},{"reference":"<p>Kelleher, K. J., Sheils, T. K., Mathias, S. L., Yang, J. J., Metzger, V. T., Siramshetty, V. B., Nguyen, D.-T., Jensen, L. J., Vidović, D., Schürer, S. C., Holmes, J., Sharma, K. R., Pillai, A., Bologa, C. G., Edwards, J. S., Mathé, E. A., &amp; Oprea, T. I. (2023). Pharos 2023: An integrated resource for the understudied human proteome. <i>Nucleic Acids Research</i>, <i>51</i>(D1), D1405–D1416. https://doi.org/10.1093/nar/gkac1033</p>","pubmedId":"","doi":""},{"reference":"<p>Moitra, T., &amp; Larrouy-Maumus, G. (2026). Integrated approaches for discovery and functional annotation of proteins of unknown function. <i>Trends in Biochemical Sciences</i>, <i>51</i>(1), 80–92. https://doi.org/10.1016/j.tibs.2025.11.001</p>","pubmedId":"","doi":""},{"reference":"<p>Nurk, S., Koren, S., Rhie, A., Rautiainen, M., Bzikadze, A. V., Mikheenko, A., Vollger, M. R., Altemose, N., Uralsky, L., Gershman, A., Aganezov, S., Hoyt, S. J., Diekhans, M., Logsdon, G. A., Alonge, M., Antonarakis, S. E., Borchers, M., Bouffard, G. G., Brooks, S. Y., … Phillippy, A. M. (2022). The complete sequence of a human genome. <i>Science</i>, <i>376</i>(6588), 44–53. https://doi.org/10.1126/science.abj6987</p>","pubmedId":"","doi":""},{"reference":"<p>Omenn, G. S., Orchard, S., Lane, L., Lindskog, C., Pineau, C., Overall, C. M., Budnik, B., Mudge, J. M., Packer, N. H., Weintraub, S. T., Roehrl, M. H. A., Nice, E., Guo, T., Van Eyk, J. E., Völker, U., Zhang, G., Bandeira, N., Aebersold, R., Moritz, R. L., &amp; Deutsch, E. W. (2024). The 2024 Report on the Human Proteome from the HUPO Human Proteome Project. <i>Journal of Proteome Research</i>, <i>23</i>(12), 5296–5311. https://doi.org/10.1021/acs.jproteome.4c00776</p>","pubmedId":"","doi":""},{"reference":"<p>Rocha, J. J., Jayaram, S. A., Stevens, T. J., Muschalik, N., Shah, R. D., Emran, S., Robles, C., Freeman, M., &amp; Munro, S. (2023). Functional unknomics: Systematic screening of conserved genes of unknown function. <i>PLOS Biology</i>, <i>21</i>(8), e3002222. https://doi.org/10.1371/journal.pbio.3002222</p>","pubmedId":"","doi":""},{"reference":"<p>Sharifi Tabar, M., Parsania, C., Chen, H., Su, X.-D., Bailey, C. G., &amp; Rasko, J. E. J. (2022). Illuminating the dark protein-protein interactome. <i>Cell Reports Methods</i>, <i>2</i>(8), 100275. https://doi.org/10.1016/j.crmeth.2022.100275</p>","pubmedId":"","doi":""}],"title":"<p>Bacterial Growth Inhibition Screen (BGIS): A Novel Method for Functional Domain Mapping and Generation of Loss-of-Function Mutants in Human Dark Proteins</p>","reviews":[{"reviewer":{"displayName":"Bryan Thurtle-Schmidt"},"openAcknowledgement":false,"status":{"submitted":true}}],"curatorReviews":[]},{"id":"eb31fb48-27b9-4573-9260-76ef90662038","decision":"edit","abstract":"<p>The human proteome holds immense therapeutic potential, yet many \"dark\" proteins remain functionally uncharacterized. We apply the Bacterial Growth Inhibition Screen (BGIS), previously validated on the DEK oncoprotein, to 29 dark human proteins. Through a three-phase screening pipeline comprising an initial growth-inhibition screen, AlphaFold-guided fragmentation, and error-prone PCR mutagenesis, BGIS identified regions associated with a growth-inhibitory phenotype in 8 of 29 proteins and, as exemplified by PBDC1, yielded candidate growth-escape mutants. This proof-of-concept study establishes BGIS as a scalable, cost-effective framework for preliminary hypothesis-independent, phenotype-level characterization of dark proteins, providing an additional experimental entry point for dark proteome research.</p>","acknowledgements":"","authors":[{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":[""],"credit":["conceptualization","dataCuration","formalAnalysis","fundingAcquisition","investigation","methodology","validation","visualization","writing_originalDraft","writing_reviewEditing"],"email":"songhe.jin@dukekunshan.edu.cn","firstName":"Songhe ","lastName":"Jin","submittingAuthor":false,"correspondingAuthor":false,"equalContribution":false,"WBId":null,"orcid":null},{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":[""],"credit":["conceptualization","dataCuration","formalAnalysis","fundingAcquisition","investigation","methodology","validation","writing_originalDraft","writing_reviewEditing"],"email":"chutian.chen@duke.edu","firstName":"Chutian ","lastName":"Chen ","submittingAuthor":false,"correspondingAuthor":false,"equalContribution":false,"WBId":null,"orcid":null},{"affiliations":["Xi'an Jiaotong-Liverpool University "],"departments":["Department of Biosciences and Bioinformatics"],"credit":["conceptualization","supervision","visualization","methodology"],"email":"yewei.liu@dukekunshan.edu.cn","firstName":"Yewei ","lastName":"Liu ","submittingAuthor":false,"correspondingAuthor":true,"equalContribution":true,"WBId":null,"orcid":"0009-0006-5666-1977"},{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":["Division of Natural and Applied Sciences"],"credit":["conceptualization","fundingAcquisition","supervision","resources","writing_reviewEditing"],"email":"Ferdinand.Kappes@dukekunshan.edu.cn","firstName":"Ferdinand","lastName":"Kappes","submittingAuthor":true,"correspondingAuthor":true,"equalContribution":true,"WBId":null,"orcid":"0000-0002-0369-0065"}],"awards":[],"conflictsOfInterest":"<p>The authors declare that there are no conflicts of interest present.</p>","dataTable":{"url":null},"extendedData":[{"description":"<p>Extended Data 1. Images of BGIS experiments supporting the screening results shown in Fig. 1B–C.</p><p>(A) Representative BGIS results of the 29 selected human dark proteins. Each protein was transformed into E. coli BL21(DE3) and plated on LB-AMP plates with (+IPTG) or without (−IPTG) IPTG induction. Growth inhibition was evaluated by comparing colony formation between induced and non-induced conditions. Among the 29 proteins screened, CAAP1, MSANTD7, and DNAJC28 exhibited a complete growth inhibition phenotype, whereas PBDC1, PPAN-P2RY11, TMX3, EVA1C, and STKLD1 exhibited a partial growth inhibition phenotype upon IPTG induction. &nbsp;(B) Representative BGIS results of protein fragments derived from the inhibitory proteins identified in (A). Protein fragments were generated based on AlphaFold2-predicted structural boundaries and screened using BGIS to localize domain-specific growth inhibition activity.</p>","doi":null,"resourceType":"Dataset","name":"Ex 1.jpg","url":"https://portal.micropublication.org/uploads/9739f2baa6fc8dfcac40564fd54d8817.jpg"},{"description":"<p>Extended Data 1. Expression analysis of all 29 human dark proteins used in this study via western blotting. </p>","doi":null,"resourceType":"Dataset","name":"Ex2 (1).jpg","url":"https://portal.micropublication.org/uploads/fa3146d00d2f877fc199dd7888b13083.jpg"}],"funding":"<p>This work was supported by internal funding from Duke Kunshan University, including the Summer Research Scholarship (SRS), Signature Work Fund (SF), Signature Work Research Grant (SWRG), a grant from the DKU Innovation Incubator (Dii), and a Start-up Fund.</p>","image":{"url":"https://portal.micropublication.org/uploads/280048cc4c1fd5c6e7dca8ae72cf59fe.jpg"},"imageCaption":"<p><b>(A) BGIS workflow. </b>Phase 1, Initial BGIS: full-length dark proteins are expressed as GST fusions in <i>E. coli</i> BL21(DE3) and screened for the growth-inhibitory phenotype (GIP) upon IPTG induction. Phase 2, Domain Specific BGIS: inhibitory proteins are fragmented along AlphaFold2-predicted structural boundaries and re-screened to localize the region associated with the GIP. Phase 3, Growth-escape mutant screen: the fragment producing the GIP is mutagenized by error-prone PCR and screened for variants capable of escape. <b>(B)</b> <b>Summary table of all 29 dark proteins screened in Phase 1.</b> PubMed scores are sourced from the Pharos/TCRD database, reflecting the limited literature representation of these dark protein candidates. Detailed selection criteria are described in the Methods section. Proteins whose induced expression produces a complete or partial GIP are highlighted in blue, whereas; proteins that do not produce a GIP are not highlighted. Full plate images are shown in Extended Data Fig. 1A<b>. (C) Summary of BGIS results for all proteins producing a growth-inhibitory phenotype and their fragments from Phases 1 and 2.</b> A complete GIP (marked as \"complete\") indicates no colony formation on +IPTG plates; a partial GIP (marked as \"partial\") indicates significantly reduced colony size on +IPTG plates relative to −IPTG controls. Full plate images are shown in Extended Data Fig. 1B. <b>(D-E)</b> <b>Proof-of-concept demonstration using PBDC1. (D) BGIS results of PBDC1, its fragmentations, and error-prone PCR mutagenesis.</b> GST empty vector and GST-DEK fusion protein served as negative and positive controls respectively. Colony plate images show BGIS results for full-length PBDC1 and its AlphaFold-guided fragments (Region 1 and Region 2), where IPTG induction drives expression of the corresponding GST-fusion protein cloned into pGEX-4T-1. Error-prone PCR (EP) was performed at two MnCl₂ concentrations 0.3% (w/v) (EP 0.3%) and 0.5% (w/v) (EP 0.5%), the resulting mutant libraries were transformed into <i>E. coli</i> BL21(DE3). Large colonies emerging on +IPTG plates represent candidate growth-escape mutants that no longer produce the growth-inhibitory phenotype and were selected for sequencing. <b>(E) Candidate growth-escape mutants in PBDC1 Region 2. </b>After excluding sequences containing indels or nonsense mutations, remaining sequences were further filtered to retain only those harboring missense mutations, discarding synonymous substitutions. The resulting nucleotide changes and corresponding amino acid substitutions are indicated. Three candidate growth-escape mutants were identified in PBDC1 Region 2. These variants have not been re-tested, and their relevance to the native biological function of PBDC1 has not been established.</p>","imageTitle":"<p>Bacterial Growth Inhibition Screen (BGIS) of 29 human dark proteins identifies regions associated with a reduced growth phenotype in <i>E. coli</i> and growth-escape mutants in PBDC1</p>","methods":"<p></p>","reagents":"<p><b>Protein Selection and Plasmid Construction</b></p><p><a>Candidate proteins were selected using the Target Development Level (TDL) classification in Pharos/TCRD </a>(Kelleher et al., 2023), focusing on proteins categorized as Tdark or low-confidence Tbio; tiers representing the least characterized fraction of the human proteome. Candidates were further filtered by two criteria: (i) the presence of at least one structurally discrete domain, as assessed by visual inspection of AlphaFold-predicted models (Jumper et al., 2021), and (ii) a Pharos PubMed Score below 50 —<b> </b>a conservative threshold well below well-studied and early-stage research targets (e.g., EGFR: 19,716; LRRK2: 2,119; DEK: 370) - indicating minimal direct representation in the biomedical literature <b>(Fig. 1B)</b>.</p><p>Additionally, three proteins absent from the Pharos/TCRD database were included as supplementary candidates to broaden the coverage of understudied targets. A0A1W2PQ72 (MSANTD7) is a reviewed Swiss-Prot entry with a UniProt annotation score of 2/5, reflecting near-absent experimental characterization. A6NDF3 (PBDC1) is an unreviewed TrEMBL entry with an annotation score of 1/5, but notably carries \"Evidence at protein level\", confirming experimental detection while remaining entirely without functional annotation. A0A0A6YYI3 (PPAN-P2RY11) is unreviewed with an annotation score of 1/5 and protein existence classified as \"Predicted\", indicating no experimental evidence for its expression or function.</p><p>Coding sequences were codon-optimized for <i>E. coli</i> BL21 (DE3) expression using the IDT Codon Optimization Tool and synthesized by GenScript. Each fragment was cloned into pGEX-4T-1 (GenScript) between the EcoRI and XhoI restriction sites, enabling IPTG-inducible expression as an N-terminal GST fusion protein. Correct insertion was confirmed by Sanger sequencing prior to use.</p><p><b>Bacterial Growth Inhibition Screen (BGIS)</b></p><p>LB agar was prepared at 40 g/L, autoclaved at 121 °C for 20 min, and supplemented with ampicillin (100 μg/mL) at ~50 °C. For BGIS plates, IPTG was additionally added to 0.1 mM at ~40 °C. Plates were dried in a biosafety cabinet and stored at 4 °C until use.</p><p>All plasmids were diluted to 10 ng/μL in nuclease-free water. Chemically competent <i>E. coli</i> BL21(DE3) cells (50 μL) were incubated with 1 μL plasmid on ice for 20 min, heat-shocked at 42 °C for 45 s, returned to ice for 5 min, and recovered in 70 μL LB for 5 min. Equal volumes (50 μL) of transformed culture were spread onto paired LB-AMP plates with and without 0.1 mM IPTG and incubated at 37 °C overnight. Colony formation was compared between conditions and proteins were classified as producing \"complete inhibition,\" \"partial inhibition,\" or \"no inhibition\" of colony formation upon induced expression. This classification is purely phenotypic: it reports growth on solid medium and does not identify a molecular activity of the expressed protein. The empty pGEX-4T-1 vector (GST alone) served as the negative control; a GST-DEK fusion protein served as the positive control (Guo et al., 2021). All BGIS analyses were carried out in triplicate, and the results were reproducible across all replicates.</p><p><b>Protein Expression and Western Blotting (Extended Data Fig. 2) </b></p><p>Single colonies were inoculated into 5 mL LB-AMP and grown overnight at 37 °C. The following day, 1 mL of overnight culture was diluted into 4 mL LB-AMP and incubated at 37 °C for 2 h. The culture was divided into two 1.5 mL aliquots; one was supplemented with 0.1 mM IPTG and both were incubated for a further 1.5 h at 37 °C.</p><p>Cells were pelleted at 8,000 rpm (6,080 × g) for 1 min, resuspended in 100 μL 2% SDS, 40% power ultrasonic disrupted (SCIENTZ Ultrasonic Homogenizer JY96-IIN) for 3-5 seconds until the solution lost its viscosity. 12 μL of lysate was combined with 3 μL 5× Laemmli Sample buffer, heated at 95 °C for 5 min, and resolved by SDS-PAGE on 10% polyacrylamide gels at 80 V (stacking) then 120 V (resolving). Proteins were transferred to PVDF membrane by semi-dry transfer at 100 mA for 75 min. After blocking with 5% skim milk in TBST, membranes were probed overnight at 4 °C with an anti-GST rabbit monoclonal antibody (1:1,000; Beyotime), washed three times in TBST, then incubated with HRP-conjugated goat anti-rabbit IgG (1:10,000; Beyotime) for 60 min at room temperature. Signal was detected by chemiluminescence (Cytiva, ImageQuant 800) and images were quantified using ImageJ.</p><p><b>AlphaFold-Guided Protein Fragmentation and Subcloning</b></p><p>Proteins that produced the growth-inhibitory phenotype were fragmented for phenotype-level mapping. Boundaries were determined from AlphaFold2-predicted structures and per-residue confidence (pLDDT) scores (https://alphafold.ebi.ac.uk/): domain interfaces were used where clear tertiary boundaries existed, and transitions from low (yellow) to very low (orange) pLDDT were used otherwise. Fragments were designed to span 80–200 amino acids.</p><p>Primers were designed with target T<sub>m</sub> of 51–56 °C and GC content of 40–60%, adding restriction enzyme cleavage site,and verified by BLAST against the constructed full length protein’s plasmid sequence. PCR was performed in 50 μL reaction system (Reagent.Table 3) with the following cycling conditions: 95 °C for 3 min; 33 cycles of 95 °C for 30 s, 56 °C for 30 s, 72 °C for 1min; final extension at 72 °C for 5 min; hold at 12 °C. Products were resolved on 1% agarose gels containing Gel Red Nucleic Acid (Adamas Life) at 120 V for 30 min, and bands of correct size were excised and purified using the QIAGEN QIAquick Gel Extraction Kit (eluted in 30 μL nuclease-free water).</p><p>Gel-purified fragments and the pGEX-4T-1 vector were digested with EcoRI and XhoI (Reagent. Table 4). For inserts containing an internal EcoRI site (e.g., protein 159), SalI was substituted for EcoRI. Digested products were column-purified prior to ligation. Ligation was carried out in a 20 μL reaction containing insertion sequence and linearized vector at a 3:1 molar ratio, 1× T4 DNA Ligase buffer, and T4 DNA Ligase (Beyotime) (Reagent. Table 5), incubated at 25 °C for 2 h or 16 °C overnight. 10 μL of ligation product was transformed into DH5α competent cells using the same heat-shock protocol described above and plated on LB-AMP agar. Colonies were screened by Sanger sequencing (Sangon Biotech, Suzhou), and verified constructs were propagated in DH5α, extracted by miniprep (QI Aprep Spin Miniprep Kit), and retransformed into BL21(DE3) for secondary BGIS.</p><p><b>Error-Prone PCR Mutagenesis</b></p><p>To generate libraries of candidate growth-escape mutants, error-prone PCR was applied to the coding sequence of each fragment that produced the growth-inhibitory phenotype, introducing random mutations. Two MnCl<sub>2</sub> concentrations were used to modulate mutation frequency (Reagent. Table 6); all other conditions were identical to standard PCR. Amplified mutant mixture were gel-purified, digested, ligated into pGEX-4T-1, and transformed into BL21(DE3) as described above. Transformants were plated on LB-AMP-IPTG plates and incubated overnight at 37 °C.</p><p>Because all selected proteins either completely or partially inhibit <i>E. coli</i> growth upon induction, colonies on +IPTG plates that carried mutated variants were visibly larger than background microcolonies, indicative of a variant that no longer produces the growth-inhibitory phenotype upon induced expression. They were designated candidate growth-escape mutants (GEMs).</p><p><b><a>Sanger Sequencing and Identification of Growth-Escape Mutants</a></b></p><p>Large colonies from +IPTG plates were picked and their plasmids extracted for Sanger sequencing (Sangon Biotech, Suzhou). Sequences were aligned to the wild-type reference using SnapGene to identify all nucleotide changes relative to the wild-type coding sequence.</p><p>Candidate sequences were then filtered using the following criteria to isolate informative growth-escape variants. First, sequences containing any insertion or deletion were excluded, as frameshift mutations would globally disrupt protein structure and preclude attribution of the phenotype to particular residues. Second, sequences harboring premature stop codons (nonsense mutations) were excluded for the same reason—truncated proteins cannot be used to reliably attribute escape from the phenotype to a specific region or residue. Third, synonymous substitutions—single-nucleotide changes that do not alter the encoded amino acid (silent mutations)—were also excluded, as they are unlikely to contribute to escape from the observed growth-inhibitory phenotype. Only sequences carrying non-synonymous single-nucleotide substitutions (missense mutations) were retained as candidate growth-escape variants.</p><p>&nbsp;Reagents</p><p>Table 1. Bacterial Strains</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Strains</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p><i>E. coli</i> BL21(DE3)pLysS</p></td><td><p>AngyuBio</p></td></tr><tr><td><p><i>E. coli</i> DH5α</p></td><td><p>AngyuBio</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 2. Plasmids</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Plasmids</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p>pGEX-4T-1</p></td><td><p>Genescript</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 3. PCR reaction system (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Final Concentration</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>to 50</p></td><td><p>—</p></td></tr><tr><td><p>10× BeyoTaq Buffer with Mg<sup>2+</sup> (Beyotime, #D7020-2)</p></td><td><p>5</p></td><td><p>1×</p></td></tr><tr><td><p>dNTP mixture (25mM) (Beyotime, #D7371 )</p></td><td><p>0.4</p></td><td><p>0.2 mM</p></td></tr><tr><td><p>Primer Forward (10 μM)</p></td><td><p>2</p></td><td><p>0.4 μM</p></td></tr><tr><td><p>Primer Reverse (10 μM)</p></td><td><p>2</p></td><td><p>0.4 μM</p></td></tr><tr><td><p>Template plasmid</p></td><td><p>—</p></td><td><p>[20 ng]</p></td></tr><tr><td><p>Beyo Taq DNA polymerase (5U/μL) (Beyotime, #D7219-1)</p></td><td><p>0.25</p></td><td><p>[1.25 U]</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 4. Restriction endonuclease digestion system (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>to 50</p></td></tr><tr><td><p>10× CutSmart buffer (New England Biolabs, #B6004S)</p></td><td><p>5</p></td></tr><tr><td><p>PCR product or vector</p></td><td><p>30</p></td></tr><tr><td><p>Restriction endonuclease</p><p>(XhoI: NEB, #R0146V; EcoRI: NEB, #R3101V)</p></td><td><p>1 each</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 5. T4 Ligation System.</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td></tr><tr><td><p>T4 DNA Ligase Buffer (NEB, #B0202S)</p></td><td><p>2</p></td></tr><tr><td><p>T4 DNA Ligase (Beyotime, #D7006-1)</p></td><td><p>0.5</p></td></tr><tr><td><p>Digested DNA Fragment (~30ng/μL)</p></td><td><p>2</p></td></tr><tr><td><p>Digested linear pGEX-4T-1 (~5ng/μL)</p></td><td><p>16</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 6. Error-prone PCR reaction systems (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>0.3 % (w/v) MnCl₂ System (μL)</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>0.5 % (w/v) MnCl₂ System (μL)</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>Up to 50</p></td><td><p>Up to 50</p></td></tr><tr><td><p>10× BeyoTaq Buffer with Mg<sup>2+</sup> (Beyotime, #D7020-2)</p></td><td><p>5</p></td><td><p>5</p></td></tr><tr><td><p>dNTP mixture (25mM) (Beyotime, #D7371 )</p></td><td><p>4</p></td><td><p>4</p></td></tr><tr><td><p>Template</p></td><td><p>1</p></td><td><p>1</p></td></tr><tr><td><p>Forward primer (10 μM)</p></td><td><p>2</p></td><td><p>2</p></td></tr><tr><td><p>Reverse primer (10 μM)</p></td><td><p>2</p></td><td><p>2</p></td></tr><tr><td><p>Beyo Taq DNA polymerase (5U/μL) (Beyotime, #D7219-1)</p></td><td><p>0.25</p></td><td><p>0.25</p></td></tr><tr><td><p>MnCl₂ 10% (w/v) stock</p></td><td><p>1.5</p></td><td><p>2.5</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 7: Protein fragmentation primers</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Primer_name</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Primer_seq</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p>Common_F</p></td><td><p>CAAAATCGGATCTGGTTCCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>Common_R</p></td><td><p>TCGTCAGTCAGTCACGATG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-1_R</p></td><td><p>TCACTCGAGCTCCAAGTCGCTGTGTTC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-2_F</p></td><td><p>TCAGAATTCGACTTGGAGGAAGGTGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-2_R</p></td><td><p>TCACTCGAGCTCCTCCATGTCCGAATCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-3_F</p></td><td><p>TCAGAATTCGAGGAGGAAGCGGATGATG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>DNAJC28-1_R</p></td><td><p>ACTCTCGAGTCACCTTTAGCCATGCTCTCCT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>DNAJC28-2_F</p></td><td><p>TCAGAATTCGGTGATTTCGATAACCTCTCCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-1_R</p></td><td><p>TCTCTCGAGTCTTCAGTTCATTCGGCTGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-2_F</p></td><td><p>TCAGAATTCGTGTCTTTTAAGTGCCAGCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-2_R</p></td><td><p>TCACTCGAGCGGCTTCAGGTTGGC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-3_F</p></td><td><p>TCAGAATTCGCGATCGCCAACCTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>MSANTD7-1_R</p></td><td><p>ACACTCGAGGCAACCAAGTTTTGATCGCAG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>MSANTD7-2_F</p></td><td><p>TCAGAATTCCACTGCGATCAAAACTTGGTT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PPAN-P2RY11-1_R</p></td><td><p>TCACTCGAGCTCTTCCTCAGTTTTGC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PPAN-P2RY11-2_F</p></td><td><p>TCAGAATTCGGCAAAGTGATGTTTCACTCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>STKLD1-1_R</p></td><td><p>ACTCTCGAGCTGCCTCTCAGGAAGGTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>STKLD1-2_F</p></td><td><p>TCAGAATTCGGCAGTTTCAAGTCCAGTTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-1_R</p></td><td><p>ACACTCGAGGAAGTGGCCGAATTAGAG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-2_F</p></td><td><p>ACAGAATTCCCACTTCCAAGTCAACAAATGT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-2_R</p></td><td><p>ACACTCGAGAAACCTTTCCCTGTTGATCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-3_F</p></td><td><p>TCAGAATTCCAGAATTACCTTGCTATGGATGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PBDC1-1_R</p></td><td><p>TCACTCGAGCGTTTCTTCTCAACGGTC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PBDC1-2_F</p></td><td><p>TCAGAATTCGTTGAGAAGAAACGTACCC</p></td><td><p>Sangon Biotech</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>","patternDescription":"<p>Despite the Human Genome Project's identification of ~20,000 protein-coding genes (Nurk et al., 2022) and large-scale efforts such as the HUPO Human Proteome Project (Omenn et al., 2024), a substantial portion of the human proteome remains functionally unannotated, the so-called \"dark proteins\", whose activities and interactions have yet to be experimentally elucidated (Cao et al., 2024).</p><p>While recent studies highlighted that many “dark” proteins indeed execute essential functions in organisms (Moitra &amp; Larrouy-Maumus, 2026; Rocha et al., 2023),<a> research on “dark” proteins remains limited, often due to a lack of molecular tools and the labor-intensive nature of the work with uncertain rewards</a> (Sharifi Tabar et al., 2022). In addition, despite structural predictions by AlphaFold, experimentally deciphering molecular function at the domain level in dark proteins presents a methodological challenge. A critical step in such studies is the generation of mutants that reduce or abolish a defined protein activity, which in turn allows that activity to be linked causally to a cellular phenotype, rather than relying solely on gene-level knockdown or knockout approaches that abolish all protein functions simultaneously (Guo, Prell, et al., 2021). Conventional site-directed mutagenesis is the standard strategy for generating such mutants; however, it requires detailed prior knowledge of protein structure and functionally important residues (Brannigan &amp; Wilkinson, 2002). For dark proteins, this information is typically unavailable.&nbsp;</p><p>Therefore, for dark proteins lacking any such prior information, an unbiased, hypothesis-independent approach to identifying the regions of a protein that produce a measurable phenotype, and to generating variants that escape that phenotype, is required.<a> To address this challenge, Guo et al. (2021) established the Bacterial Growth Inhibition Screen (BGIS) for the study of proteins.</a> Using this strategy, we previously identified a mutant of the DEK oncoprotein that no longer produces a growth-inhibitory phenotype; for DEK, this phenotype has been linked to direct DNA compaction. These results demonstrate that, in a protein for which an independent activity assay exists, BGIS can point to residues relevant to a defined molecular activity in a fully hypothesis-independent manner (Guo, Prell, et al., 2021; Guo, Xu, et al., 2021).</p><p>However, BGIS has only been validated on protein (DEK) with known functions, and its applicability to dark proteins, where no functional or structural reference exists, remains unexplored. One barrier lies in domain fragmentation: localizing the growth-inhibitory phenotype to a specific region of a full-length protein requires rational boundaries for fragmentation, information that is unavailable for dark proteins. The release of AlphaFold2, which provides relatively high-confidence structural predictions for protein sequences, offers a solution to this problem by enabling structure-guided fragmentation without experimental structural data. In this study, we integrate BGIS with AlphaFold2-predicted domain boundaries to systematically screen human dark proteins for the growth-inhibitory phenotype, to localize the regions associated with it, and to generate candidate growth-escape mutants, establishing a proof-of-concept workflow for hypothesis-independent, phenotype-level characterization of the dark proteome.</p><p>Throughout this manuscript we use “phenotype” in a strict, operational sense. Heterologous overexpression of a non-native protein in <i>E. coli</i> can reduce growth for reasons that are unrelated to the protein's native biological function, including protein misfolding, aggregation, or other effects. We therefore do not directly equate reduced growth with molecular activity, and we do not infer native function from these experiments. Accordingly, we use “growth-inhibitory phenotype (GIP)” for reduced colony formation or reduced colony size upon IPTG-induced expression from the plasmid, “GIP-associated region” for a fragment that still produces the GIP when expressed, and “growth-escape mutant (GEM)” for a variant that no longer produces such a phenotype. None of these terms implies that the corresponding region, residue, or substitution is required for the native biological function of the human protein; establishing that would require an independent activity assay and validation in a eukaryotic context.</p><p>To test if human \"dark proteins\" produce a GIP in <i>E. coli</i>, we screened 29 human dark proteins through a three-phase BGIS pipeline <b>(Fig. 1A)</b>. In Phase 1, each protein was expressed as a GST fusion in <i>E. coli</i> BL21(DE3) and assessed for growth inhibition upon IPTG induction, using GST alone as a negative control and the DEK oncoprotein as a positive control (Guo, Prell, et al., 2021). Growth inhibition was defined as either complete absence of colony formation or a significant reduction in colony size on inducing plates relative to non-inducing controls (Fig. 1D), identifying candidates that produce a detectable growth-inhibitory phenotype (GIP). Proteins that produced the growth-inhibitory phenotype were carried into Phase 2, where AlphaFold2-predicted structural boundaries guided the design of protein fragments <b>(Fig. 1D)</b>, allowing the growth-inhibitory phenotype to be localized to a defined region without relying on experimental structural data. In Phase 3, the inhibitory domain was subjected to error-prone PCR mutagenesis to generate random variant libraries; colonies that escaped growth inhibition were then selected as candidate growth-escape mutants, with confirmed missense substitutions identified by sequencing.</p><p>&nbsp;</p><p><a>Of the 29 dark proteins screened in Phase 1, eight exhibited complete or partial growth inhibition upon IPTG induction </a><b><a>(Fig. 1B)</a></b><a>, indicating that while BGIS is not universally applicable, a meaningful fraction of dark proteins produces a growth-inhibitory phenotype detectable by this approach. In Phase 2, </a>AlphaFold2-guided fragmentation localized the growth-inhibitory phenotype to a defined region in 6 of these proteins (<b>Fig. 1C</b>), supporting the utility of structure-predicted boundaries as a fragmentation strategy. To demonstrate the complete three-phase workflow, PBDC1 was taken through Phase 3 as a proof-of-concept example <b>(Fig. 1D–1E)</b>. Phase 2 fragmentation revealed that both region 1 and region 2 of PBDC1 independently retained the growth-inhibitory phenotype, with region 1 producing complete inhibition and Region 2 producing partial inhibition <b>(Fig. 1D)</b>. Error-prone PCR mutagenesis was performed on both regions; however, only region 2 yielded candidate growth-escape mutants after sequencing-based filtering to exclude nonsense and frameshift variants. Three variants carrying missense substitutions were identified in region 2, each carrying 2-3 amino acid substitutions, identifying residues that are associated with the growth-inhibitory phenotype in PBDC1 (<b>Fig. 1E</b>). These variants are candidates only: they have not been re-tested, and their relevance to the native biological function of PBDC1 has not been established.</p><p>Together, the screening of 29 human dark proteins, including phenotype-level mapping of the regions responsible for reduced growth in 6 of them, offers a preliminary reference that may serve as an entry point for future investigations into these uncharacterized proteins. For PBDC1 specifically, Phase 2 fragmentation and Phase 3 mutagenesis further yielded three candidate growth-escape variants in region 2, identifying residues associated with the phenotype and providing starting points for future mechanistic investigation. Moreover, the successful application of BGIS to human dark proteins serves as a proof-of-concept of a fast, low-cost workflow that requires no prior functional assumptions. While not universally applicable, this approach offers a practical methodology for researchers encountering bottlenecks in the phenotypic characterization of uncharacterized proteins and in the generation of variants that escape a given phenotype.</p><p>Several caveats and limitations should be noted. First, the mechanism underlying growth inhibition has not been experimentally verified for each dark protein screened; unlike DEK, whose toxicity was linked to direct DNA compaction (Guo, Prell, et al., 2021). Thus, the basis of inhibition in other candidates remains unknown, and growth inhibition alone cannot be taken as evidence of any particular molecular activity, nor of the protein's native biological function, in a eukaryotic context. Second, the AlphaFold2-guided fragmentation strategy relies on empirical identification of structural boundaries based on the visual clustering of secondary structure elements, which is subjective and may not correspond to genuine structural or functional boundaries. The reliability of this approach is further constrained by regional variations in AlphaFold2 prediction confidence (pLDDT scores), particularly in intrinsically disordered regions where boundary assignments are less certain. Third, the screen covers 29 proteins, and conclusions regarding the broader applicability of BGIS to the dark proteome should be interpreted with caution.<a> </a>Fourth, the error-prone PCR mutagenesis condition requires further optimization. The MnCl₂ concentration, the primary determinant of mutation load, proved difficult to control in practice: high concentrations introduced multiple substitutions per clone rather than the ideal single missense mutation, making it laborious to determine the key substitution responsible for escape from the phenotype. On the other hand, concentrations that were low failed to yield enough validated missense mutants because of a high proportion of nonsense mutations; a limitation particularly pronounced for Region 1 of PBDC1.</p><p>Finally, the candidate growth-escape mutants identified here have not been subjected to reversion mutagenesis, nor have the confirmed substitutions been reintroduced into full-length PBDC1 and re-expressed in <i>E. coli</i> to verify their effect in the intact protein context. As all validations were performed solely at the bacterial level, whether these substitutions affect the native biological function of PBDC1 in a eukaryotic context also remains to be determined. Future studies could perform reversion mutagenesis to define the minimal set of substitutions required to escape the phenotype, reintroducing confirmed mutations into full-length PBDC1 for bacterial re-expression, and ultimately characterizing these proteins and their growth-escape variants in human cells to obtain eukaryotic context information.</p>","references":[{"reference":"<p>Brannigan, J. A., &amp; Wilkinson, A. J. (2002). Protein engineering 20 years on. <i>Nature Reviews Molecular Cell Biology</i>, <i>3</i>(12), 964–970. https://doi.org/10.1038/nrm975</p>","pubmedId":"","doi":""},{"reference":"<p>Cao, X., Sun, S., &amp; Xing, J. (2024). A Massive Proteogenomic Screen Identifies Thousands of Novel Peptides From the Human “Dark” Proteome. <i>Molecular &amp; Cellular Proteomics: MCP</i>, <i>23</i>(2), 100719. https://doi.org/10.1016/j.mcpro.2024.100719</p>","pubmedId":"","doi":""},{"reference":"<p>Guo, H., Prell, M., Königs, H., Xu, N., Waldmann, T., Hermans‐Sachweh, B., Ferrando‐May, E., Lüscher, B., &amp; Kappes, F. (2021). Bacterial Growth Inhibition Screen (BGIS) identifies a loss‐of‐function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin. <i>FEBS Letters</i>, <i>595</i>(10), 1438–1453. https://doi.org/10.1002/1873-3468.14070</p>","pubmedId":"","doi":""},{"reference":"<p>Guo, H., Xu, N., Prell, M., Königs, H., Hermanns-Sachweh, B., Lüscher, B., &amp; Kappes, F. (2021). Bacterial Growth Inhibition Screen (BGIS): Harnessing recombinant protein toxicity for rapid and unbiased interrogation of protein function. <i>FEBS Letters</i>, <i>595</i>(10), 1422–1437. https://doi.org/10.1002/1873-3468.14072</p>","pubmedId":"","doi":""},{"reference":"<p>Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., Bridgland, A., Meyer, C., Kohl, S. A. A., Ballard, A. J., Cowie, A., Romera-Paredes, B., Nikolov, S., Jain, R., Adler, J., … Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. <i>Nature</i>, <i>596</i>(7873), 583–589. https://doi.org/10.1038/s41586-021-03819-2</p>","pubmedId":"","doi":""},{"reference":"<p>Kelleher, K. J., Sheils, T. K., Mathias, S. L., Yang, J. J., Metzger, V. T., Siramshetty, V. B., Nguyen, D.-T., Jensen, L. J., Vidović, D., Schürer, S. C., Holmes, J., Sharma, K. R., Pillai, A., Bologa, C. G., Edwards, J. S., Mathé, E. A., &amp; Oprea, T. I. (2023). Pharos 2023: An integrated resource for the understudied human proteome. <i>Nucleic Acids Research</i>, <i>51</i>(D1), D1405–D1416. https://doi.org/10.1093/nar/gkac1033</p>","pubmedId":"","doi":""},{"reference":"<p>Moitra, T., &amp; Larrouy-Maumus, G. (2026). Integrated approaches for discovery and functional annotation of proteins of unknown function. <i>Trends in Biochemical Sciences</i>, <i>51</i>(1), 80–92. https://doi.org/10.1016/j.tibs.2025.11.001</p>","pubmedId":"","doi":""},{"reference":"<p>Nurk, S., Koren, S., Rhie, A., Rautiainen, M., Bzikadze, A. V., Mikheenko, A., Vollger, M. R., Altemose, N., Uralsky, L., Gershman, A., Aganezov, S., Hoyt, S. J., Diekhans, M., Logsdon, G. A., Alonge, M., Antonarakis, S. E., Borchers, M., Bouffard, G. G., Brooks, S. Y., … Phillippy, A. M. (2022). The complete sequence of a human genome. <i>Science</i>, <i>376</i>(6588), 44–53. https://doi.org/10.1126/science.abj6987</p>","pubmedId":"","doi":""},{"reference":"<p>Omenn, G. S., Orchard, S., Lane, L., Lindskog, C., Pineau, C., Overall, C. M., Budnik, B., Mudge, J. M., Packer, N. H., Weintraub, S. T., Roehrl, M. H. A., Nice, E., Guo, T., Van Eyk, J. E., Völker, U., Zhang, G., Bandeira, N., Aebersold, R., Moritz, R. L., &amp; Deutsch, E. W. (2024). The 2024 Report on the Human Proteome from the HUPO Human Proteome Project. <i>Journal of Proteome Research</i>, <i>23</i>(12), 5296–5311. https://doi.org/10.1021/acs.jproteome.4c00776</p>","pubmedId":"","doi":""},{"reference":"<p>Rocha, J. J., Jayaram, S. A., Stevens, T. J., Muschalik, N., Shah, R. D., Emran, S., Robles, C., Freeman, M., &amp; Munro, S. (2023). Functional unknomics: Systematic screening of conserved genes of unknown function. <i>PLOS Biology</i>, <i>21</i>(8), e3002222. https://doi.org/10.1371/journal.pbio.3002222</p>","pubmedId":"","doi":""},{"reference":"<p>Sharifi Tabar, M., Parsania, C., Chen, H., Su, X.-D., Bailey, C. G., &amp; Rasko, J. E. J. (2022). Illuminating the dark protein-protein interactome. <i>Cell Reports Methods</i>, <i>2</i>(8), 100275. https://doi.org/10.1016/j.crmeth.2022.100275</p>","pubmedId":"","doi":""}],"title":"<p>Bacterial Growth Inhibition Screen (BGIS): an unconventional phenotype-based workflow for mapping regions in human dark proteins associated with reduced growth in <i>E. coli.</i></p>","reviews":[{"reviewer":{"displayName":"Bryan Thurtle-Schmidt"},"openAcknowledgement":false,"status":{"submitted":true}}],"curatorReviews":[]},{"id":"2d6c6831-9a58-40b2-8bf6-5dc9b157d7e4","decision":"accept","abstract":"<p>The human proteome holds immense therapeutic potential, yet many \"dark\" proteins remain functionally uncharacterized. We apply the Bacterial Growth Inhibition Screen (BGIS), previously validated on the DEK oncoprotein, to 29 dark human proteins. Through a three-phase screening pipeline comprising an initial growth-inhibition screen, AlphaFold-guided fragmentation, and error-prone PCR mutagenesis, BGIS identified regions associated with a growth-inhibitory phenotype in 8 of 29 proteins and, as exemplified by PBDC1, yielded candidate growth-escape mutants. This proof-of-concept study establishes BGIS as a scalable, cost-effective framework for preliminary hypothesis-independent, phenotype-level characterization of dark proteins, providing an additional experimental entry point for dark proteome research.</p>","acknowledgements":"","authors":[{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":[""],"credit":["conceptualization","dataCuration","formalAnalysis","fundingAcquisition","investigation","methodology","validation","visualization","writing_originalDraft","writing_reviewEditing"],"email":"songhe.jin@dukekunshan.edu.cn","firstName":"Songhe ","lastName":"Jin","submittingAuthor":false,"correspondingAuthor":false,"equalContribution":false,"WBId":null,"orcid":null},{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":[""],"credit":["conceptualization","dataCuration","formalAnalysis","fundingAcquisition","investigation","methodology","validation","writing_originalDraft","writing_reviewEditing"],"email":"chutian.chen@duke.edu","firstName":"Chutian ","lastName":"Chen ","submittingAuthor":false,"correspondingAuthor":false,"equalContribution":false,"WBId":null,"orcid":null},{"affiliations":["Xi'an Jiaotong-Liverpool University "],"departments":["Department of Biosciences and Bioinformatics"],"credit":["conceptualization","supervision","visualization","methodology"],"email":"yewei.liu@dukekunshan.edu.cn","firstName":"Yewei ","lastName":"Liu ","submittingAuthor":false,"correspondingAuthor":true,"equalContribution":true,"WBId":null,"orcid":"0009-0006-5666-1977"},{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":["Division of Natural and Applied Sciences"],"credit":["conceptualization","fundingAcquisition","supervision","resources","writing_reviewEditing"],"email":"Ferdinand.Kappes@dukekunshan.edu.cn","firstName":"Ferdinand","lastName":"Kappes","submittingAuthor":true,"correspondingAuthor":true,"equalContribution":true,"WBId":null,"orcid":"0000-0002-0369-0065"}],"awards":[],"conflictsOfInterest":"<p>The authors declare that there are no conflicts of interest present.</p>","dataTable":{"url":null},"extendedData":[{"description":"<p>Extended Data 1. Images of BGIS experiments supporting the screening results shown in Fig. 1B–C.</p><p>(A) Representative BGIS results of the 29 selected human dark proteins. Each protein was transformed into E. coli BL21(DE3) and plated on LB-AMP plates with (+IPTG) or without (−IPTG) IPTG induction. Growth inhibition was evaluated by comparing colony formation between induced and non-induced conditions. Among the 29 proteins screened, CAAP1, MSANTD7, and DNAJC28 exhibited a complete growth inhibition phenotype, whereas PBDC1, PPAN-P2RY11, TMX3, EVA1C, and STKLD1 exhibited a partial growth inhibition phenotype upon IPTG induction. &nbsp;(B) Representative BGIS results of protein fragments derived from the inhibitory proteins identified in (A). Protein fragments were generated based on AlphaFold2-predicted structural boundaries and screened using BGIS to localize domain-specific growth inhibition activity.</p>","doi":"10.22002/yrmf4-jre15","resourceType":"Dataset","name":"Ex 1.jpg","url":"https://portal.micropublication.org/uploads/9739f2baa6fc8dfcac40564fd54d8817.jpg"},{"description":"<p>Extended Data 1. Expression analysis of all 29 human dark proteins used in this study via western blotting.</p>","doi":"10.22002/nmqzn-p5719","resourceType":"Dataset","name":"Ex2 (1).jpg","url":"https://portal.micropublication.org/uploads/fa3146d00d2f877fc199dd7888b13083.jpg"}],"funding":"<p>This work was supported by internal funding from Duke Kunshan University, including the Summer Research Scholarship (SRS), Signature Work Fund (SF), Signature Work Research Grant (SWRG), a grant from the DKU Innovation Incubator (Dii), and a Start-up Fund.</p>","image":{"url":"https://portal.micropublication.org/uploads/280048cc4c1fd5c6e7dca8ae72cf59fe.jpg"},"imageCaption":"<p><b>(A) BGIS workflow. </b>Phase 1, Initial BGIS: full-length dark proteins are expressed as GST fusions in <i>E. coli</i> BL21(DE3) and screened for the growth-inhibitory phenotype (GIP) upon IPTG induction. Phase 2, Domain Specific BGIS: inhibitory proteins are fragmented along AlphaFold2-predicted structural boundaries and re-screened to localize the region associated with the GIP. Phase 3, Growth-escape mutant screen: the fragment producing the GIP is mutagenized by error-prone PCR and screened for variants capable of escape. <b>(B)</b> <b>Summary table of all 29 dark proteins screened in Phase 1.</b> PubMed scores are sourced from the Pharos/TCRD database, reflecting the limited literature representation of these dark protein candidates. Detailed selection criteria are described in the Methods section. Proteins whose induced expression produces a complete or partial GIP are highlighted in blue, whereas; proteins that do not produce a GIP are not highlighted. Full plate images are shown in Extended Data Fig. 1A<b>. (C) Summary of BGIS results for all proteins producing a growth-inhibitory phenotype and their fragments from Phases 1 and 2.</b> A complete GIP (marked as \"complete\") indicates no colony formation on +IPTG plates; a partial GIP (marked as \"partial\") indicates significantly reduced colony size on +IPTG plates relative to −IPTG controls. Full plate images are shown in Extended Data Fig. 1B. <b>(D-E)</b> <b>Proof-of-concept demonstration using PBDC1. (D) BGIS results of PBDC1, its fragmentations, and error-prone PCR mutagenesis.</b> GST empty vector and GST-DEK fusion protein served as negative and positive controls respectively. Colony plate images show BGIS results for full-length PBDC1 and its AlphaFold-guided fragments (Region 1 and Region 2), where IPTG induction drives expression of the corresponding GST-fusion protein cloned into pGEX-4T-1. Error-prone PCR (EP) was performed at two MnCl₂ concentrations 0.3% (w/v) (EP 0.3%) and 0.5% (w/v) (EP 0.5%), the resulting mutant libraries were transformed into <i>E. coli</i> BL21(DE3). Large colonies emerging on +IPTG plates represent candidate growth-escape mutants that no longer produce the growth-inhibitory phenotype and were selected for sequencing. <b>(E) Candidate growth-escape mutants in PBDC1 Region 2. </b>After excluding sequences containing indels or nonsense mutations, remaining sequences were further filtered to retain only those harboring missense mutations, discarding synonymous substitutions. The resulting nucleotide changes and corresponding amino acid substitutions are indicated. Three candidate growth-escape mutants were identified in PBDC1 Region 2. These variants have not been re-tested, and their relevance to the native biological function of PBDC1 has not been established.</p>","imageTitle":"<p>Bacterial Growth Inhibition Screen (BGIS) of 29 human dark proteins identifies regions associated with a reduced growth phenotype in <i>E. coli</i> and growth-escape mutants in PBDC1</p>","methods":"<p><b>Protein Selection and Plasmid Construction</b></p><p><a>Candidate proteins were selected using the Target Development Level (TDL) classification in Pharos/TCRD </a>(Kelleher et al., 2023), focusing on proteins categorized as Tdark or low-confidence Tbio; tiers representing the least characterized fraction of the human proteome. Candidates were further filtered by two criteria: (i) the presence of at least one structurally discrete domain, as assessed by visual inspection of AlphaFold-predicted models (Jumper et al., 2021), and (ii) a Pharos PubMed Score below 50 —<b> </b>a conservative threshold well below well-studied and early-stage research targets (e.g., EGFR: 19,716; LRRK2: 2,119; DEK: 370) - indicating minimal direct representation in the biomedical literature <b>(Fig. 1B)</b>.</p><p>Additionally, three proteins absent from the Pharos/TCRD database were included as supplementary candidates to broaden the coverage of understudied targets. A0A1W2PQ72 (MSANTD7) is a reviewed Swiss-Prot entry with a UniProt annotation score of 2/5, reflecting near-absent experimental characterization. A6NDF3 (PBDC1) is an unreviewed TrEMBL entry with an annotation score of 1/5, but notably carries \"Evidence at protein level\", confirming experimental detection while remaining entirely without functional annotation. A0A0A6YYI3 (PPAN-P2RY11) is unreviewed with an annotation score of 1/5 and protein existence classified as \"Predicted\", indicating no experimental evidence for its expression or function.</p><p>Coding sequences were codon-optimized for <i>E. coli</i> BL21 (DE3) expression using the IDT Codon Optimization Tool and synthesized by GenScript. Each fragment was cloned into pGEX-4T-1 (GenScript) between the EcoRI and XhoI restriction sites, enabling IPTG-inducible expression as an N-terminal GST fusion protein. Correct insertion was confirmed by Sanger sequencing prior to use.</p><p><b>Bacterial Growth Inhibition Screen (BGIS)</b></p><p>LB agar was prepared at 40 g/L, autoclaved at 121 °C for 20 min, and supplemented with ampicillin (100 μg/mL) at ~50 °C. For BGIS plates, IPTG was additionally added to 0.1 mM at ~40 °C. Plates were dried in a biosafety cabinet and stored at 4 °C until use.</p><p>All plasmids were diluted to 10 ng/μL in nuclease-free water. Chemically competent <i>E. coli</i> BL21(DE3) cells (50 μL) were incubated with 1 μL plasmid on ice for 20 min, heat-shocked at 42 °C for 45 s, returned to ice for 5 min, and recovered in 70 μL LB for 5 min. Equal volumes (50 μL) of transformed culture were spread onto paired LB-AMP plates with and without 0.1 mM IPTG and incubated at 37 °C overnight. Colony formation was compared between conditions and proteins were classified as producing \"complete inhibition,\" \"partial inhibition,\" or \"no inhibition\" of colony formation upon induced expression. This classification is purely phenotypic: it reports growth on solid medium and does not identify a molecular activity of the expressed protein. The empty pGEX-4T-1 vector (GST alone) served as the negative control; a GST-DEK fusion protein served as the positive control (Guo et al., 2021). All BGIS analyses were carried out in triplicate, and the results were reproducible across all replicates.</p><p><b>Protein Expression and Western Blotting (Extended Data Fig. 2)</b></p><p>Single colonies were inoculated into 5 mL LB-AMP and grown overnight at 37 °C. The following day, 1 mL of overnight culture was diluted into 4 mL LB-AMP and incubated at 37 °C for 2 h. The culture was divided into two 1.5 mL aliquots; one was supplemented with 0.1 mM IPTG and both were incubated for a further 1.5 h at 37 °C.</p><p>Cells were pelleted at 8,000 rpm (6,080 × g) for 1 min, resuspended in 100 μL 2% SDS, 40% power ultrasonic disrupted (SCIENTZ Ultrasonic Homogenizer JY96-IIN) for 3-5 seconds until the solution lost its viscosity. 12 μL of lysate was combined with 3 μL 5× Laemmli Sample buffer, heated at 95 °C for 5 min, and resolved by SDS-PAGE on 10% polyacrylamide gels at 80 V (stacking) then 120 V (resolving). Proteins were transferred to PVDF membrane by semi-dry transfer at 100 mA for 75 min. After blocking with 5% skim milk in TBST, membranes were probed overnight at 4 °C with an anti-GST rabbit monoclonal antibody (1:1,000; Beyotime), washed three times in TBST, then incubated with HRP-conjugated goat anti-rabbit IgG (1:10,000; Beyotime) for 60 min at room temperature. Signal was detected by chemiluminescence (Cytiva, ImageQuant 800) and images were quantified using ImageJ.</p><p><b>AlphaFold-Guided Protein Fragmentation and Subcloning</b></p><p>Proteins that produced the growth-inhibitory phenotype were fragmented for phenotype-level mapping. Boundaries were determined from AlphaFold2-predicted structures and per-residue confidence (pLDDT) scores (https://alphafold.ebi.ac.uk/): domain interfaces were used where clear tertiary boundaries existed, and transitions from low (yellow) to very low (orange) pLDDT were used otherwise. Fragments were designed to span 80–200 amino acids.</p><p>Primers were designed with target T<sub>m</sub> of 51–56 °C and GC content of 40–60%, adding restriction enzyme cleavage site,and verified by BLAST against the constructed full length protein’s plasmid sequence. PCR was performed in 50 μL reaction system (Reagent.Table 3) with the following cycling conditions: 95 °C for 3 min; 33 cycles of 95 °C for 30 s, 56 °C for 30 s, 72 °C for 1min; final extension at 72 °C for 5 min; hold at 12 °C. Products were resolved on 1% agarose gels containing Gel Red Nucleic Acid (Adamas Life) at 120 V for 30 min, and bands of correct size were excised and purified using the QIAGEN QIAquick Gel Extraction Kit (eluted in 30 μL nuclease-free water).</p><p>Gel-purified fragments and the pGEX-4T-1 vector were digested with EcoRI and XhoI (Reagent. Table 4). For inserts containing an internal EcoRI site (e.g., protein 159), SalI was substituted for EcoRI. Digested products were column-purified prior to ligation. Ligation was carried out in a 20 μL reaction containing insertion sequence and linearized vector at a 3:1 molar ratio, 1× T4 DNA Ligase buffer, and T4 DNA Ligase (Beyotime) (Reagent. Table 5), incubated at 25 °C for 2 h or 16 °C overnight. 10 μL of ligation product was transformed into DH5α competent cells using the same heat-shock protocol described above and plated on LB-AMP agar. Colonies were screened by Sanger sequencing (Sangon Biotech, Suzhou), and verified constructs were propagated in DH5α, extracted by miniprep (QI Aprep Spin Miniprep Kit), and retransformed into BL21(DE3) for secondary BGIS.</p><p><b>Error-Prone PCR Mutagenesis</b></p><p>To generate libraries of candidate growth-escape mutants, error-prone PCR was applied to the coding sequence of each fragment that produced the growth-inhibitory phenotype, introducing random mutations. Two MnCl<sub>2</sub> concentrations were used to modulate mutation frequency (Reagent. Table 6); all other conditions were identical to standard PCR. Amplified mutant mixture were gel-purified, digested, ligated into pGEX-4T-1, and transformed into BL21(DE3) as described above. Transformants were plated on LB-AMP-IPTG plates and incubated overnight at 37 °C.</p><p>Because all selected proteins either completely or partially inhibit <i>E. coli</i> growth upon induction, colonies on +IPTG plates that carried mutated variants were visibly larger than background microcolonies, indicative of a variant that no longer produces the growth-inhibitory phenotype upon induced expression. They were designated candidate growth-escape mutants (GEMs).</p><p><b><a>Sanger Sequencing and Identification of Growth-Escape Mutants</a></b></p><p>Large colonies from +IPTG plates were picked and their plasmids extracted for Sanger sequencing (Sangon Biotech, Suzhou). Sequences were aligned to the wild-type reference using SnapGene to identify all nucleotide changes relative to the wild-type coding sequence.</p><p>Candidate sequences were then filtered using the following criteria to isolate informative growth-escape variants. First, sequences containing any insertion or deletion were excluded, as frameshift mutations would globally disrupt protein structure and preclude attribution of the phenotype to particular residues. Second, sequences harboring premature stop codons (nonsense mutations) were excluded for the same reason—truncated proteins cannot be used to reliably attribute escape from the phenotype to a specific region or residue. Third, synonymous substitutions—single-nucleotide changes that do not alter the encoded amino acid (silent mutations)—were also excluded, as they are unlikely to contribute to escape from the observed growth-inhibitory phenotype. Only sequences carrying non-synonymous single-nucleotide substitutions (missense mutations) were retained as candidate growth-escape variants.</p>","reagents":"<p>Table 1. Bacterial Strains</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Strains</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p><i>E. coli</i> BL21(DE3)pLysS</p></td><td><p>AngyuBio</p></td></tr><tr><td><p><i>E. coli</i> DH5α</p></td><td><p>AngyuBio</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 2. Plasmids</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Plasmids</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p>pGEX-4T-1</p></td><td><p>Genescript</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 3. PCR reaction system (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Final Concentration</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>to 50</p></td><td><p>—</p></td></tr><tr><td><p>10× BeyoTaq Buffer with Mg<sup>2+</sup> (Beyotime, #D7020-2)</p></td><td><p>5</p></td><td><p>1×</p></td></tr><tr><td><p>dNTP mixture (25mM) (Beyotime, #D7371 )</p></td><td><p>0.4</p></td><td><p>0.2 mM</p></td></tr><tr><td><p>Primer Forward (10 μM)</p></td><td><p>2</p></td><td><p>0.4 μM</p></td></tr><tr><td><p>Primer Reverse (10 μM)</p></td><td><p>2</p></td><td><p>0.4 μM</p></td></tr><tr><td><p>Template plasmid</p></td><td><p>—</p></td><td><p>[20 ng]</p></td></tr><tr><td><p>Beyo Taq DNA polymerase (5U/μL) (Beyotime, #D7219-1)</p></td><td><p>0.25</p></td><td><p>[1.25 U]</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 4. Restriction endonuclease digestion system (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>to 50</p></td></tr><tr><td><p>10× CutSmart buffer (New England Biolabs, #B6004S)</p></td><td><p>5</p></td></tr><tr><td><p>PCR product or vector</p></td><td><p>30</p></td></tr><tr><td><p>Restriction endonuclease</p><p>(XhoI: NEB, #R0146V; EcoRI: NEB, #R3101V)</p></td><td><p>1 each</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 5. T4 Ligation System.</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td></tr><tr><td><p>T4 DNA Ligase Buffer (NEB, #B0202S)</p></td><td><p>2</p></td></tr><tr><td><p>T4 DNA Ligase (Beyotime, #D7006-1)</p></td><td><p>0.5</p></td></tr><tr><td><p>Digested DNA Fragment (~30ng/μL)</p></td><td><p>2</p></td></tr><tr><td><p>Digested linear pGEX-4T-1 (~5ng/μL)</p></td><td><p>16</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 6. Error-prone PCR reaction systems (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>0.3 % (w/v) MnCl₂ System (μL)</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>0.5 % (w/v) MnCl₂ System (μL)</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>Up to 50</p></td><td><p>Up to 50</p></td></tr><tr><td><p>10× BeyoTaq Buffer with Mg<sup>2+</sup> (Beyotime, #D7020-2)</p></td><td><p>5</p></td><td><p>5</p></td></tr><tr><td><p>dNTP mixture (25mM) (Beyotime, #D7371 )</p></td><td><p>4</p></td><td><p>4</p></td></tr><tr><td><p>Template</p></td><td><p>1</p></td><td><p>1</p></td></tr><tr><td><p>Forward primer (10 μM)</p></td><td><p>2</p></td><td><p>2</p></td></tr><tr><td><p>Reverse primer (10 μM)</p></td><td><p>2</p></td><td><p>2</p></td></tr><tr><td><p>Beyo Taq DNA polymerase (5U/μL) (Beyotime, #D7219-1)</p></td><td><p>0.25</p></td><td><p>0.25</p></td></tr><tr><td><p>MnCl₂ 10% (w/v) stock</p></td><td><p>1.5</p></td><td><p>2.5</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 7: Protein fragmentation primers</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Primer_name</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Primer_seq</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p>Common_F</p></td><td><p>CAAAATCGGATCTGGTTCCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>Common_R</p></td><td><p>TCGTCAGTCAGTCACGATG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-1_R</p></td><td><p>TCACTCGAGCTCCAAGTCGCTGTGTTC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-2_F</p></td><td><p>TCAGAATTCGACTTGGAGGAAGGTGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-2_R</p></td><td><p>TCACTCGAGCTCCTCCATGTCCGAATCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-3_F</p></td><td><p>TCAGAATTCGAGGAGGAAGCGGATGATG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>DNAJC28-1_R</p></td><td><p>ACTCTCGAGTCACCTTTAGCCATGCTCTCCT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>DNAJC28-2_F</p></td><td><p>TCAGAATTCGGTGATTTCGATAACCTCTCCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-1_R</p></td><td><p>TCTCTCGAGTCTTCAGTTCATTCGGCTGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-2_F</p></td><td><p>TCAGAATTCGTGTCTTTTAAGTGCCAGCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-2_R</p></td><td><p>TCACTCGAGCGGCTTCAGGTTGGC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-3_F</p></td><td><p>TCAGAATTCGCGATCGCCAACCTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>MSANTD7-1_R</p></td><td><p>ACACTCGAGGCAACCAAGTTTTGATCGCAG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>MSANTD7-2_F</p></td><td><p>TCAGAATTCCACTGCGATCAAAACTTGGTT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PPAN-P2RY11-1_R</p></td><td><p>TCACTCGAGCTCTTCCTCAGTTTTGC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PPAN-P2RY11-2_F</p></td><td><p>TCAGAATTCGGCAAAGTGATGTTTCACTCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>STKLD1-1_R</p></td><td><p>ACTCTCGAGCTGCCTCTCAGGAAGGTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>STKLD1-2_F</p></td><td><p>TCAGAATTCGGCAGTTTCAAGTCCAGTTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-1_R</p></td><td><p>ACACTCGAGGAAGTGGCCGAATTAGAG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-2_F</p></td><td><p>ACAGAATTCCCACTTCCAAGTCAACAAATGT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-2_R</p></td><td><p>ACACTCGAGAAACCTTTCCCTGTTGATCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-3_F</p></td><td><p>TCAGAATTCCAGAATTACCTTGCTATGGATGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PBDC1-1_R</p></td><td><p>TCACTCGAGCGTTTCTTCTCAACGGTC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PBDC1-2_F</p></td><td><p>TCAGAATTCGTTGAGAAGAAACGTACCC</p></td><td><p>Sangon Biotech</p></td></tr></tbody></table>","patternDescription":"<p>Despite the Human Genome Project's identification of ~20,000 protein-coding genes (Nurk et al., 2022) and large-scale efforts such as the HUPO Human Proteome Project (Omenn et al., 2024), a substantial portion of the human proteome remains functionally unannotated, the so-called \"dark proteins\", whose activities and interactions have yet to be experimentally elucidated (Cao et al., 2024).</p><p>While recent studies highlighted that many “dark” proteins indeed execute essential functions in organisms (Moitra &amp; Larrouy-Maumus, 2026; Rocha et al., 2023),<a> research on “dark” proteins remains limited, often due to a lack of molecular tools and the labor-intensive nature of the work with uncertain rewards</a> (Sharifi Tabar et al., 2022). In addition, despite structural predictions by AlphaFold, experimentally deciphering molecular function at the domain level in dark proteins presents a methodological challenge. A critical step in such studies is the generation of mutants that reduce or abolish a defined protein activity, which in turn allows that activity to be linked causally to a cellular phenotype, rather than relying solely on gene-level knockdown or knockout approaches that abolish all protein functions simultaneously (Guo, Prell, et al., 2021). Conventional site-directed mutagenesis is the standard strategy for generating such mutants; however, it requires detailed prior knowledge of protein structure and functionally important residues (Brannigan &amp; Wilkinson, 2002). For dark proteins, this information is typically unavailable.&nbsp;</p><p>Therefore, for dark proteins lacking any such prior information, an unbiased, hypothesis-independent approach to identifying the regions of a protein that produce a measurable phenotype, and to generating variants that escape that phenotype, is required.<a> To address this challenge, Guo et al. (2021) established the Bacterial Growth Inhibition Screen (BGIS) for the study of proteins.</a> Using this strategy, we previously identified a mutant of the DEK oncoprotein that no longer produces a growth-inhibitory phenotype; for DEK, this phenotype has been linked to direct DNA compaction. These results demonstrate that, in a protein for which an independent activity assay exists, BGIS can point to residues relevant to a defined molecular activity in a fully hypothesis-independent manner (Guo, Prell, et al., 2021; Guo, Xu, et al., 2021).</p><p>However, BGIS has only been validated on protein (DEK) with known functions, and its applicability to dark proteins, where no functional or structural reference exists, remains unexplored. One barrier lies in domain fragmentation: localizing the growth-inhibitory phenotype to a specific region of a full-length protein requires rational boundaries for fragmentation, information that is unavailable for dark proteins. The release of AlphaFold2, which provides relatively high-confidence structural predictions for protein sequences, offers a solution to this problem by enabling structure-guided fragmentation without experimental structural data. In this study, we integrate BGIS with AlphaFold2-predicted domain boundaries to systematically screen human dark proteins for the growth-inhibitory phenotype, to localize the regions associated with it, and to generate candidate growth-escape mutants, establishing a proof-of-concept workflow for hypothesis-independent, phenotype-level characterization of the dark proteome.</p><p>Throughout this manuscript we use “phenotype” in a strict, operational sense. Heterologous overexpression of a non-native protein in <i>E. coli</i> can reduce growth for reasons that are unrelated to the protein's native biological function, including protein misfolding, aggregation, or other effects. We therefore do not directly equate reduced growth with molecular activity, and we do not infer native function from these experiments. Accordingly, we use “growth-inhibitory phenotype (GIP)” for reduced colony formation or reduced colony size upon IPTG-induced expression from the plasmid, “GIP-associated region” for a fragment that still produces the GIP when expressed, and “growth-escape mutant (GEM)” for a variant that no longer produces such a phenotype. None of these terms implies that the corresponding region, residue, or substitution is required for the native biological function of the human protein; establishing that would require an independent activity assay and validation in a eukaryotic context.</p><p>To test if human \"dark proteins\" produce a GIP in <i>E. coli</i>, we screened 29 human dark proteins through a three-phase BGIS pipeline <b>(Fig. 1A)</b>. In Phase 1, each protein was expressed as a GST fusion in <i>E. coli</i> BL21(DE3) and assessed for growth inhibition upon IPTG induction, using GST alone as a negative control and the DEK oncoprotein as a positive control (Guo, Prell, et al., 2021). Growth inhibition was defined as either complete absence of colony formation or a significant reduction in colony size on inducing plates relative to non-inducing controls (Fig. 1D), identifying candidates that produce a detectable growth-inhibitory phenotype (GIP). Proteins that produced the growth-inhibitory phenotype were carried into Phase 2, where AlphaFold2-predicted structural boundaries guided the design of protein fragments <b>(Fig. 1D)</b>, allowing the growth-inhibitory phenotype to be localized to a defined region without relying on experimental structural data. In Phase 3, the inhibitory domain was subjected to error-prone PCR mutagenesis to generate random variant libraries; colonies that escaped growth inhibition were then selected as candidate growth-escape mutants, with confirmed missense substitutions identified by sequencing.</p><p><a>Of the 29 dark proteins screened in Phase 1, eight exhibited complete or partial growth inhibition upon IPTG induction </a><b><a>(Fig. 1B)</a></b><a>, indicating that while BGIS is not universally applicable, a meaningful fraction of dark proteins produces a growth-inhibitory phenotype detectable by this approach. In Phase 2, </a>AlphaFold2-guided fragmentation localized the growth-inhibitory phenotype to a defined region in 6 of these proteins (<b>Fig. 1C</b>), supporting the utility of structure-predicted boundaries as a fragmentation strategy. To demonstrate the complete three-phase workflow, PBDC1 was taken through Phase 3 as a proof-of-concept example <b>(Fig. 1D–1E)</b>. Phase 2 fragmentation revealed that both region 1 and region 2 of PBDC1 independently retained the growth-inhibitory phenotype, with region 1 producing complete inhibition and Region 2 producing partial inhibition <b>(Fig. 1D)</b>. Error-prone PCR mutagenesis was performed on both regions; however, only region 2 yielded candidate growth-escape mutants after sequencing-based filtering to exclude nonsense and frameshift variants. Three variants carrying missense substitutions were identified in region 2, each carrying 2-3 amino acid substitutions, identifying residues that are associated with the growth-inhibitory phenotype in PBDC1 (<b>Fig. 1E</b>). These variants are candidates only: they have not been re-tested, and their relevance to the native biological function of PBDC1 has not been established.</p><p>Together, the screening of 29 human dark proteins, including phenotype-level mapping of the regions responsible for reduced growth in 6 of them, offers a preliminary reference that may serve as an entry point for future investigations into these uncharacterized proteins. For PBDC1 specifically, Phase 2 fragmentation and Phase 3 mutagenesis further yielded three candidate growth-escape variants in region 2, identifying residues associated with the phenotype and providing starting points for future mechanistic investigation. Moreover, the successful application of BGIS to human dark proteins serves as a proof-of-concept of a fast, low-cost workflow that requires no prior functional assumptions. While not universally applicable, this approach offers a practical methodology for researchers encountering bottlenecks in the phenotypic characterization of uncharacterized proteins and in the generation of variants that escape a given phenotype.</p><p>Several caveats and limitations should be noted. First, the mechanism underlying growth inhibition has not been experimentally verified for each dark protein screened; unlike DEK, whose toxicity was linked to direct DNA compaction (Guo, Prell, et al., 2021). Thus, the basis of inhibition in other candidates remains unknown, and growth inhibition alone cannot be taken as evidence of any particular molecular activity, nor of the protein's native biological function, in a eukaryotic context. Second, the AlphaFold2-guided fragmentation strategy relies on empirical identification of structural boundaries based on the visual clustering of secondary structure elements, which is subjective and may not correspond to genuine structural or functional boundaries. The reliability of this approach is further constrained by regional variations in AlphaFold2 prediction confidence (pLDDT scores), particularly in intrinsically disordered regions where boundary assignments are less certain. Third, the screen covers 29 proteins, and conclusions regarding the broader applicability of BGIS to the dark proteome should be interpreted with caution.<a> </a>Fourth, the error-prone PCR mutagenesis condition requires further optimization. The MnCl₂ concentration, the primary determinant of mutation load, proved difficult to control in practice: high concentrations introduced multiple substitutions per clone rather than the ideal single missense mutation, making it laborious to determine the key substitution responsible for escape from the phenotype. On the other hand, concentrations that were low failed to yield enough validated missense mutants because of a high proportion of nonsense mutations; a limitation particularly pronounced for Region 1 of PBDC1.</p><p>Finally, the candidate growth-escape mutants identified here have not been subjected to reversion mutagenesis, nor have the confirmed substitutions been reintroduced into full-length PBDC1 and re-expressed in <i>E. coli</i> to verify their effect in the intact protein context. As all validations were performed solely at the bacterial level, whether these substitutions affect the native biological function of PBDC1 in a eukaryotic context also remains to be determined. Future studies could perform reversion mutagenesis to define the minimal set of substitutions required to escape the phenotype, reintroducing confirmed mutations into full-length PBDC1 for bacterial re-expression, and ultimately characterizing these proteins and their growth-escape variants in human cells to obtain eukaryotic context information.</p>","references":[{"reference":"<p>Brannigan JA, Wilkinson AJ. 2002. Protein engineering 20 years on. Nature Reviews Molecular Cell Biology 3: 964-970.</p>","pubmedId":"","doi":"10.1038/nrm975"},{"reference":"<p>Cao X, Sun S, Xing J. 2024. A Massive Proteogenomic Screen Identifies Thousands of Novel Peptides From the Human “Dark” Proteome. Molecular &amp; Cellular Proteomics 23: 100719.</p>","pubmedId":"","doi":"10.1016/j.mcpro.2024.100719"},{"reference":"<p>Guo H, Prell M, Königs H, Xu N, Waldmann T, Hermans‐Sachweh B, et al., Kappes. 2021. Bacterial Growth Inhibition Screen (BGIS) identifies a loss‐of‐function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin. FEBS Letters 595: 1438-1453.</p>","pubmedId":"","doi":"10.1002/1873-3468.14070"},{"reference":"<p>Guo H, Xu N, Prell M, Königs H, Hermanns‐Sachweh B, Lüscher B, Kappes F. 2021. Bacterial Growth Inhibition Screen (BGIS): harnessing recombinant protein toxicity for rapid and unbiased interrogation of protein function. FEBS Letters 595: 1422-1437.</p>","pubmedId":"","doi":"10.1002/1873-3468.14072"},{"reference":"<p>Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al., Hassabis. 2021. Highly accurate protein structure prediction with AlphaFold. Nature 596: 583-589.</p>","pubmedId":"","doi":"10.1038/s41586-021-03819-2"},{"reference":"<p>Kelleher KJ, Sheils TK, Mathias SL, Yang JJ, Metzger VT, Siramshetty VB, et al., Oprea. 2022. Pharos 2023: an integrated resource for the understudied human proteome. Nucleic Acids Research 51: D1405-D1416.</p>","pubmedId":"","doi":"10.1093/nar/gkac1033"},{"reference":"<p>Moitra T, Larrouy-Maumus G. 2026. Integrated approaches for discovery and functional annotation of proteins of unknown function. Trends in Biochemical Sciences 51: 80-92.</p>","pubmedId":"","doi":"10.1016/j.tibs.2025.11.001"},{"reference":"<p>Nurk S, Koren S, Rhie A, Rautiainen M, Bzikadze AV, Mikheenko A, et al., Phillippy. 2022. The complete sequence of a human genome. Science 376: 44-53.</p>","pubmedId":"","doi":"10.1126/science.abj6987"},{"reference":"<p>Omenn GS, Orchard S, Lane L, Lindskog C, Pineau C, Overall CM, et al., Deutsch. 2024. The 2024 Report on the Human Proteome from the HUPO Human Proteome Project. Journal of Proteome Research 23: 5296-5311.</p>","pubmedId":"","doi":"10.1021/acs.jproteome.4c00776"},{"reference":"<p>Rocha JoJ, Jayaram SA, Stevens TJ, Muschalik N, Shah RD, Emran S, et al., Munro. 2023. Functional unknomics: Systematic screening of conserved genes of unknown function. PLOS Biology 21: e3002222.</p>","pubmedId":"","doi":"10.1371/journal.pbio.3002222"},{"reference":"<p>Sharifi Tabar M, Parsania C, Chen H, Su XD, Bailey CG, Rasko JEJ. 2022. Illuminating the dark protein-protein interactome. Cell Reports Methods 2: 100275.</p>","pubmedId":"","doi":"10.1016/j.crmeth.2022.100275"}],"title":"<p>Bacterial Growth Inhibition Screen (BGIS): an unconventional phenotype-based workflow for mapping regions in human dark proteins associated with reduced growth in <i>E. coli.</i></p>","reviews":[],"curatorReviews":[]},{"id":"f8dc055a-4d90-4820-9f2b-0844f9315c9f","decision":"edit","abstract":"<p>The human proteome holds immense therapeutic potential, yet many \"dark\" proteins remain functionally uncharacterized. We apply the Bacterial Growth Inhibition Screen (BGIS), previously validated on the DEK oncoprotein, to 29 dark human proteins. Through a three-phase screening pipeline comprising an initial growth-inhibition screen, AlphaFold-guided fragmentation, and error-prone PCR mutagenesis, BGIS identified regions associated with a growth-inhibitory phenotype in 8 of 29 proteins and, as exemplified by PBDC1, yielded candidate growth-escape mutants. This proof-of-concept study establishes BGIS as a scalable, cost-effective framework for preliminary hypothesis-independent, phenotype-level characterization of dark proteins, providing an additional experimental entry point for dark proteome research.</p>","acknowledgements":"","authors":[{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":[""],"credit":["conceptualization","dataCuration","formalAnalysis","fundingAcquisition","investigation","methodology","validation","visualization","writing_originalDraft","writing_reviewEditing"],"email":"songhe.jin@dukekunshan.edu.cn","firstName":"Songhe ","lastName":"Jin","submittingAuthor":false,"correspondingAuthor":false,"equalContribution":false,"WBId":null,"orcid":null},{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":[""],"credit":["conceptualization","dataCuration","formalAnalysis","fundingAcquisition","investigation","methodology","validation","writing_originalDraft","writing_reviewEditing"],"email":"chutian.chen@duke.edu","firstName":"Chutian ","lastName":"Chen ","submittingAuthor":false,"correspondingAuthor":false,"equalContribution":false,"WBId":null,"orcid":null},{"affiliations":["Xi'an Jiaotong-Liverpool University "],"departments":["Department of Biosciences and Bioinformatics"],"credit":["conceptualization","supervision","visualization","methodology"],"email":"yewei.liu@dukekunshan.edu.cn","firstName":"Yewei ","lastName":"Liu ","submittingAuthor":false,"correspondingAuthor":true,"equalContribution":true,"WBId":null,"orcid":"0009-0006-5666-1977"},{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":["Division of Natural and Applied Sciences"],"credit":["conceptualization","fundingAcquisition","supervision","resources","writing_reviewEditing"],"email":"Ferdinand.Kappes@dukekunshan.edu.cn","firstName":"Ferdinand","lastName":"Kappes","submittingAuthor":true,"correspondingAuthor":true,"equalContribution":true,"WBId":null,"orcid":"0000-0002-0369-0065"}],"awards":[],"conflictsOfInterest":"<p>The authors declare that there are no conflicts of interest present.</p>","dataTable":{"url":null},"extendedData":[{"description":"<p>Extended Data 1. Images of BGIS experiments supporting the screening results shown in Fig. 1B–C.</p><p>(A) Representative BGIS results of the 29 selected human dark proteins. Each protein was transformed into E. coli BL21(DE3) and plated on LB-AMP plates with (+IPTG) or without (−IPTG) IPTG induction. Growth inhibition was evaluated by comparing colony formation between induced and non-induced conditions. Among the 29 proteins screened, CAAP1, MSANTD7, and DNAJC28 exhibited a complete growth inhibition phenotype, whereas PBDC1, PPAN-P2RY11, TMX3, EVA1C, and STKLD1 exhibited a partial growth inhibition phenotype upon IPTG induction. &nbsp;(B) Representative BGIS results of protein fragments derived from the inhibitory proteins identified in (A). Protein fragments were generated based on AlphaFold2-predicted structural boundaries and screened using BGIS to localize domain-specific growth inhibition activity.</p>","doi":"10.22002/yrmf4-jre15","resourceType":"Dataset","name":"Ex 1.jpg","url":"https://portal.micropublication.org/uploads/9739f2baa6fc8dfcac40564fd54d8817.jpg"},{"description":"<p>Extended Data 2. Expression analysis of all 29 human dark proteins used in this study via western blotting.</p>","doi":"10.22002/nmqzn-p5719","resourceType":"Dataset","name":"Ex2 (1).jpg","url":"https://portal.micropublication.org/uploads/fa3146d00d2f877fc199dd7888b13083.jpg"}],"funding":"<p>This work was supported by internal funding from Duke Kunshan University, including the Summer Research Scholarship (SRS), Signature Work Fund (SF), Signature Work Research Grant (SWRG), a grant from the DKU Innovation Incubator (Dii), and a Start-up Fund.</p>","image":{"url":"https://portal.micropublication.org/uploads/280048cc4c1fd5c6e7dca8ae72cf59fe.jpg"},"imageCaption":"<p><b>(A) BGIS workflow. </b>Phase 1, Initial BGIS: full-length dark proteins are expressed as GST fusions in <i>E. coli</i> BL21(DE3) and screened for the growth-inhibitory phenotype (GIP) upon IPTG induction. Phase 2, Domain Specific BGIS: inhibitory proteins are fragmented along AlphaFold2-predicted structural boundaries and re-screened to localize the region associated with the GIP. Phase 3, Growth-escape mutant screen: the fragment producing the GIP is mutagenized by error-prone PCR and screened for variants capable of escape. <b>(B)</b> <b>Summary table of all 29 dark proteins screened in Phase 1.</b> PubMed scores are sourced from the Pharos/TCRD database, reflecting the limited literature representation of these dark protein candidates. Detailed selection criteria are described in the Methods section. Proteins whose induced expression produces a complete or partial GIP are highlighted in blue, whereas; proteins that do not produce a GIP are not highlighted. Full plate images are shown in Extended Data Fig. 1A<b>. (C) Summary of BGIS results for all proteins producing a growth-inhibitory phenotype and their fragments from Phases 1 and 2.</b> A complete GIP (marked as \"complete\") indicates no colony formation on +IPTG plates; a partial GIP (marked as \"partial\") indicates significantly reduced colony size on +IPTG plates relative to −IPTG controls. Full plate images are shown in Extended Data Fig. 1B. <b>(D-E)</b> <b>Proof-of-concept demonstration using PBDC1. (D) BGIS results of PBDC1, its fragmentations, and error-prone PCR mutagenesis.</b> GST empty vector and GST-DEK fusion protein served as negative and positive controls respectively. Colony plate images show BGIS results for full-length PBDC1 and its AlphaFold-guided fragments (Region 1 and Region 2), where IPTG induction drives expression of the corresponding GST-fusion protein cloned into pGEX-4T-1. Error-prone PCR (EP) was performed at two MnCl₂ concentrations 0.3% (w/v) (EP 0.3%) and 0.5% (w/v) (EP 0.5%), the resulting mutant libraries were transformed into <i>E. coli</i> BL21(DE3). Large colonies emerging on +IPTG plates represent candidate growth-escape mutants that no longer produce the growth-inhibitory phenotype and were selected for sequencing. <b>(E) Candidate growth-escape mutants in PBDC1 Region 2. </b>After excluding sequences containing indels or nonsense mutations, remaining sequences were further filtered to retain only those harboring missense mutations, discarding synonymous substitutions. The resulting nucleotide changes and corresponding amino acid substitutions are indicated. Three candidate growth-escape mutants were identified in PBDC1 Region 2. These variants have not been re-tested, and their relevance to the native biological function of PBDC1 has not been established.</p>","imageTitle":"<p>Bacterial Growth Inhibition Screen (BGIS) of 29 human dark proteins identifies regions associated with a reduced growth phenotype in <i>E. coli</i> and growth-escape mutants in PBDC1</p>","methods":"<p><b>Protein Selection and Plasmid Construction</b></p><p><a>Candidate proteins were selected using the Target Development Level (TDL) classification in Pharos/TCRD </a>(Kelleher et al., 2023), focusing on proteins categorized as Tdark or low-confidence Tbio; tiers representing the least characterized fraction of the human proteome. Candidates were further filtered by two criteria: (i) the presence of at least one structurally discrete domain, as assessed by visual inspection of AlphaFold-predicted models (Jumper et al., 2021), and (ii) a Pharos PubMed Score below 50 —<b> </b>a conservative threshold well below well-studied and early-stage research targets (e.g., EGFR: 19,716; LRRK2: 2,119; DEK: 370) - indicating minimal direct representation in the biomedical literature <b>(Fig. 1B)</b>.</p><p>Additionally, three proteins absent from the Pharos/TCRD database were included as supplementary candidates to broaden the coverage of understudied targets. A0A1W2PQ72 (MSANTD7) is a reviewed Swiss-Prot entry with a UniProt annotation score of 2/5, reflecting near-absent experimental characterization. A6NDF3 (PBDC1) is an unreviewed TrEMBL entry with an annotation score of 1/5, but notably carries \"Evidence at protein level\", confirming experimental detection while remaining entirely without functional annotation. A0A0A6YYI3 (PPAN-P2RY11) is unreviewed with an annotation score of 1/5 and protein existence classified as \"Predicted\", indicating no experimental evidence for its expression or function.</p><p>Coding sequences were codon-optimized for <i>E. coli</i> BL21 (DE3) expression using the IDT Codon Optimization Tool and synthesized by GenScript. Each fragment was cloned into pGEX-4T-1 (GenScript) between the EcoRI and XhoI restriction sites, enabling IPTG-inducible expression as an N-terminal GST fusion protein. Correct insertion was confirmed by Sanger sequencing prior to use.</p><p><b>Bacterial Growth Inhibition Screen (BGIS)</b></p><p>LB agar was prepared at 40 g/L, autoclaved at 121 °C for 20 min, and supplemented with ampicillin (100 μg/mL) at ~50 °C. For BGIS plates, IPTG was additionally added to 0.1 mM at ~40 °C. Plates were dried in a biosafety cabinet and stored at 4 °C until use.</p><p>All plasmids were diluted to 10 ng/μL in nuclease-free water. Chemically competent <i>E. coli</i> BL21(DE3) cells (50 μL) were incubated with 1 μL plasmid on ice for 20 min, heat-shocked at 42 °C for 45 s, returned to ice for 5 min, and recovered in 70 μL LB for 5 min. Equal volumes (50 μL) of transformed culture were spread onto paired LB-AMP plates with and without 0.1 mM IPTG and incubated at 37 °C overnight. Colony formation was compared between conditions and proteins were classified as producing \"complete inhibition,\" \"partial inhibition,\" or \"no inhibition\" of colony formation upon induced expression. This classification is purely phenotypic: it reports growth on solid medium and does not identify a molecular activity of the expressed protein. The empty pGEX-4T-1 vector (GST alone) served as the negative control; a GST-DEK fusion protein served as the positive control (Guo et al., 2021). All BGIS analyses were carried out in triplicate, and the results were reproducible across all replicates.</p><p><b>Protein Expression and Western Blotting (Extended Data Fig. 2)</b></p><p>Single colonies were inoculated into 5 mL LB-AMP and grown overnight at 37 °C. The following day, 1 mL of overnight culture was diluted into 4 mL LB-AMP and incubated at 37 °C for 2 h. The culture was divided into two 1.5 mL aliquots; one was supplemented with 0.1 mM IPTG and both were incubated for a further 1.5 h at 37 °C.</p><p>Cells were pelleted at 8,000 rpm (6,080 × g) for 1 min, resuspended in 100 μL 2% SDS, 40% power ultrasonic disrupted (SCIENTZ Ultrasonic Homogenizer JY96-IIN) for 3-5 seconds until the solution lost its viscosity. 12 μL of lysate was combined with 3 μL 5× Laemmli Sample buffer, heated at 95 °C for 5 min, and resolved by SDS-PAGE on 10% polyacrylamide gels at 80 V (stacking) then 120 V (resolving). Proteins were transferred to PVDF membrane by semi-dry transfer at 100 mA for 75 min. After blocking with 5% skim milk in TBST, membranes were probed overnight at 4 °C with an anti-GST rabbit monoclonal antibody (1:1,000; Beyotime), washed three times in TBST, then incubated with HRP-conjugated goat anti-rabbit IgG (1:10,000; Beyotime) for 60 min at room temperature. Signal was detected by chemiluminescence (Cytiva, ImageQuant 800) and images were quantified using ImageJ.</p><p><b>AlphaFold-Guided Protein Fragmentation and Subcloning</b></p><p>Proteins that produced the growth-inhibitory phenotype were fragmented for phenotype-level mapping. Boundaries were determined from AlphaFold2-predicted structures and per-residue confidence (pLDDT) scores (https://alphafold.ebi.ac.uk/): domain interfaces were used where clear tertiary boundaries existed, and transitions from low (yellow) to very low (orange) pLDDT were used otherwise. Fragments were designed to span 80–200 amino acids.</p><p>Primers were designed with target T<sub>m</sub> of 51–56 °C and GC content of 40–60%, adding restriction enzyme cleavage site,and verified by BLAST against the constructed full length protein’s plasmid sequence. PCR was performed in 50 μL reaction system (Reagent.Table 3) with the following cycling conditions: 95 °C for 3 min; 33 cycles of 95 °C for 30 s, 56 °C for 30 s, 72 °C for 1min; final extension at 72 °C for 5 min; hold at 12 °C. Products were resolved on 1% agarose gels containing Gel Red Nucleic Acid (Adamas Life) at 120 V for 30 min, and bands of correct size were excised and purified using the QIAGEN QIAquick Gel Extraction Kit (eluted in 30 μL nuclease-free water).</p><p>Gel-purified fragments and the pGEX-4T-1 vector were digested with EcoRI and XhoI (Reagent. Table 4). For inserts containing an internal EcoRI site (e.g., protein 159), SalI was substituted for EcoRI. Digested products were column-purified prior to ligation. Ligation was carried out in a 20 μL reaction containing insertion sequence and linearized vector at a 3:1 molar ratio, 1× T4 DNA Ligase buffer, and T4 DNA Ligase (Beyotime) (Reagent. Table 5), incubated at 25 °C for 2 h or 16 °C overnight. 10 μL of ligation product was transformed into DH5α competent cells using the same heat-shock protocol described above and plated on LB-AMP agar. Colonies were screened by Sanger sequencing (Sangon Biotech, Suzhou), and verified constructs were propagated in DH5α, extracted by miniprep (QI Aprep Spin Miniprep Kit), and retransformed into BL21(DE3) for secondary BGIS.</p><p><b>Error-Prone PCR Mutagenesis</b></p><p>To generate libraries of candidate growth-escape mutants, error-prone PCR was applied to the coding sequence of each fragment that produced the growth-inhibitory phenotype, introducing random mutations. Two MnCl<sub>2</sub> concentrations were used to modulate mutation frequency (Reagent. Table 6); all other conditions were identical to standard PCR. Amplified mutant mixture were gel-purified, digested, ligated into pGEX-4T-1, and transformed into BL21(DE3) as described above. Transformants were plated on LB-AMP-IPTG plates and incubated overnight at 37 °C.</p><p>Because all selected proteins either completely or partially inhibit <i>E. coli</i> growth upon induction, colonies on +IPTG plates that carried mutated variants were visibly larger than background microcolonies, indicative of a variant that no longer produces the growth-inhibitory phenotype upon induced expression. They were designated candidate growth-escape mutants (GEMs).</p><p><b><a>Sanger Sequencing and Identification of Growth-Escape Mutants</a></b></p><p>Large colonies from +IPTG plates were picked and their plasmids extracted for Sanger sequencing (Sangon Biotech, Suzhou). Sequences were aligned to the wild-type reference using SnapGene to identify all nucleotide changes relative to the wild-type coding sequence.</p><p>Candidate sequences were then filtered using the following criteria to isolate informative growth-escape variants. First, sequences containing any insertion or deletion were excluded, as frameshift mutations would globally disrupt protein structure and preclude attribution of the phenotype to particular residues. Second, sequences harboring premature stop codons (nonsense mutations) were excluded for the same reason—truncated proteins cannot be used to reliably attribute escape from the phenotype to a specific region or residue. Third, synonymous substitutions—single-nucleotide changes that do not alter the encoded amino acid (silent mutations)—were also excluded, as they are unlikely to contribute to escape from the observed growth-inhibitory phenotype. Only sequences carrying non-synonymous single-nucleotide substitutions (missense mutations) were retained as candidate growth-escape variants.</p>","reagents":"<p>Table 1. Bacterial Strains</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Strains</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p><i>E. coli</i> BL21(DE3)pLysS</p></td><td><p>AngyuBio</p></td></tr><tr><td><p><i>E. coli</i> DH5α</p></td><td><p>AngyuBio</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 2. Plasmids</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Plasmids</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p>pGEX-4T-1</p></td><td><p>Genescript</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 3. PCR reaction system (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Final Concentration</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>to 50</p></td><td><p>—</p></td></tr><tr><td><p>10× BeyoTaq Buffer with Mg<sup>2+</sup> (Beyotime, #D7020-2)</p></td><td><p>5</p></td><td><p>1×</p></td></tr><tr><td><p>dNTP mixture (25mM) (Beyotime, #D7371 )</p></td><td><p>0.4</p></td><td><p>0.2 mM</p></td></tr><tr><td><p>Primer Forward (10 μM)</p></td><td><p>2</p></td><td><p>0.4 μM</p></td></tr><tr><td><p>Primer Reverse (10 μM)</p></td><td><p>2</p></td><td><p>0.4 μM</p></td></tr><tr><td><p>Template plasmid</p></td><td><p>—</p></td><td><p>[20 ng]</p></td></tr><tr><td><p>Beyo Taq DNA polymerase (5U/μL) (Beyotime, #D7219-1)</p></td><td><p>0.25</p></td><td><p>[1.25 U]</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 4. Restriction endonuclease digestion system (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>to 50</p></td></tr><tr><td><p>10× CutSmart buffer (New England Biolabs, #B6004S)</p></td><td><p>5</p></td></tr><tr><td><p>PCR product or vector</p></td><td><p>30</p></td></tr><tr><td><p>Restriction endonuclease</p><p>(XhoI: NEB, #R0146V; EcoRI: NEB, #R3101V)</p></td><td><p>1 each</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 5. T4 Ligation System.</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td></tr><tr><td><p>T4 DNA Ligase Buffer (NEB, #B0202S)</p></td><td><p>2</p></td></tr><tr><td><p>T4 DNA Ligase (Beyotime, #D7006-1)</p></td><td><p>0.5</p></td></tr><tr><td><p>Digested DNA Fragment (~30ng/μL)</p></td><td><p>2</p></td></tr><tr><td><p>Digested linear pGEX-4T-1 (~5ng/μL)</p></td><td><p>16</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 6. Error-prone PCR reaction systems (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>0.3 % (w/v) MnCl₂ System (μL)</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>0.5 % (w/v) MnCl₂ System (μL)</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>Up to 50</p></td><td><p>Up to 50</p></td></tr><tr><td><p>10× BeyoTaq Buffer with Mg<sup>2+</sup> (Beyotime, #D7020-2)</p></td><td><p>5</p></td><td><p>5</p></td></tr><tr><td><p>dNTP mixture (25mM) (Beyotime, #D7371 )</p></td><td><p>4</p></td><td><p>4</p></td></tr><tr><td><p>Template</p></td><td><p>1</p></td><td><p>1</p></td></tr><tr><td><p>Forward primer (10 μM)</p></td><td><p>2</p></td><td><p>2</p></td></tr><tr><td><p>Reverse primer (10 μM)</p></td><td><p>2</p></td><td><p>2</p></td></tr><tr><td><p>Beyo Taq DNA polymerase (5U/μL) (Beyotime, #D7219-1)</p></td><td><p>0.25</p></td><td><p>0.25</p></td></tr><tr><td><p>MnCl₂ 10% (w/v) stock</p></td><td><p>1.5</p></td><td><p>2.5</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 7: Protein fragmentation primers</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Primer_name</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Primer_seq</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p>Common_F</p></td><td><p>CAAAATCGGATCTGGTTCCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>Common_R</p></td><td><p>TCGTCAGTCAGTCACGATG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-1_R</p></td><td><p>TCACTCGAGCTCCAAGTCGCTGTGTTC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-2_F</p></td><td><p>TCAGAATTCGACTTGGAGGAAGGTGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-2_R</p></td><td><p>TCACTCGAGCTCCTCCATGTCCGAATCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-3_F</p></td><td><p>TCAGAATTCGAGGAGGAAGCGGATGATG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>DNAJC28-1_R</p></td><td><p>ACTCTCGAGTCACCTTTAGCCATGCTCTCCT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>DNAJC28-2_F</p></td><td><p>TCAGAATTCGGTGATTTCGATAACCTCTCCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-1_R</p></td><td><p>TCTCTCGAGTCTTCAGTTCATTCGGCTGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-2_F</p></td><td><p>TCAGAATTCGTGTCTTTTAAGTGCCAGCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-2_R</p></td><td><p>TCACTCGAGCGGCTTCAGGTTGGC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-3_F</p></td><td><p>TCAGAATTCGCGATCGCCAACCTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>MSANTD7-1_R</p></td><td><p>ACACTCGAGGCAACCAAGTTTTGATCGCAG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>MSANTD7-2_F</p></td><td><p>TCAGAATTCCACTGCGATCAAAACTTGGTT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PPAN-P2RY11-1_R</p></td><td><p>TCACTCGAGCTCTTCCTCAGTTTTGC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PPAN-P2RY11-2_F</p></td><td><p>TCAGAATTCGGCAAAGTGATGTTTCACTCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>STKLD1-1_R</p></td><td><p>ACTCTCGAGCTGCCTCTCAGGAAGGTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>STKLD1-2_F</p></td><td><p>TCAGAATTCGGCAGTTTCAAGTCCAGTTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-1_R</p></td><td><p>ACACTCGAGGAAGTGGCCGAATTAGAG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-2_F</p></td><td><p>ACAGAATTCCCACTTCCAAGTCAACAAATGT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-2_R</p></td><td><p>ACACTCGAGAAACCTTTCCCTGTTGATCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-3_F</p></td><td><p>TCAGAATTCCAGAATTACCTTGCTATGGATGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PBDC1-1_R</p></td><td><p>TCACTCGAGCGTTTCTTCTCAACGGTC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PBDC1-2_F</p></td><td><p>TCAGAATTCGTTGAGAAGAAACGTACCC</p></td><td><p>Sangon Biotech</p></td></tr></tbody></table>","patternDescription":"<p>Despite the Human Genome Project's identification of ~20,000 protein-coding genes (Nurk et al., 2022) and large-scale efforts such as the HUPO Human Proteome Project (Omenn et al., 2024), a substantial portion of the human proteome remains functionally unannotated, the so-called \"dark proteins\", whose activities and interactions have yet to be experimentally elucidated (Cao et al., 2024).</p><p>While recent studies highlighted that many “dark” proteins indeed execute essential functions in organisms (Moitra &amp; Larrouy-Maumus, 2026; Rocha et al., 2023),<a> research on “dark” proteins remains limited, often due to a lack of molecular tools and the labor-intensive nature of the work with uncertain rewards</a> (Sharifi Tabar et al., 2022). In addition, despite structural predictions by AlphaFold, experimentally deciphering molecular function at the domain level in dark proteins presents a methodological challenge. A critical step in such studies is the generation of mutants that reduce or abolish a defined protein activity, which in turn allows that activity to be linked causally to a cellular phenotype, rather than relying solely on gene-level knockdown or knockout approaches that abolish all protein functions simultaneously (Guo, Prell, et al., 2021). Conventional site-directed mutagenesis is the standard strategy for generating such mutants; however, it requires detailed prior knowledge of protein structure and functionally important residues (Brannigan &amp; Wilkinson, 2002). For dark proteins, this information is typically unavailable.&nbsp;</p><p>Therefore, for dark proteins lacking any such prior information, an unbiased, hypothesis-independent approach to identifying the regions of a protein that produce a measurable phenotype, and to generating variants that escape that phenotype, is required.<a> To address this challenge, Guo et al. (2021) established the Bacterial Growth Inhibition Screen (BGIS) for the study of proteins.</a> Using this strategy, we previously identified a mutant of the DEK oncoprotein that no longer produces a growth-inhibitory phenotype; for DEK, this phenotype has been linked to direct DNA compaction. These results demonstrate that, in a protein for which an independent activity assay exists, BGIS can point to residues relevant to a defined molecular activity in a fully hypothesis-independent manner (Guo, Prell, et al., 2021; Guo, Xu, et al., 2021).</p><p>However, BGIS has only been validated on protein (DEK) with known functions, and its applicability to dark proteins, where no functional or structural reference exists, remains unexplored. One barrier lies in domain fragmentation: localizing the growth-inhibitory phenotype to a specific region of a full-length protein requires rational boundaries for fragmentation, information that is unavailable for dark proteins. The release of AlphaFold2, which provides relatively high-confidence structural predictions for protein sequences, offers a solution to this problem by enabling structure-guided fragmentation without experimental structural data. In this study, we integrate BGIS with AlphaFold2-predicted domain boundaries to systematically screen human dark proteins for the growth-inhibitory phenotype, to localize the regions associated with it, and to generate candidate growth-escape mutants, establishing a proof-of-concept workflow for hypothesis-independent, phenotype-level characterization of the dark proteome.</p><p>Throughout this manuscript we use “phenotype” in a strict, operational sense. Heterologous overexpression of a non-native protein in <i>E. coli</i> can reduce growth for reasons that are unrelated to the protein's native biological function, including protein misfolding, aggregation, or other effects. We therefore do not directly equate reduced growth with molecular activity, and we do not infer native function from these experiments. Accordingly, we use “growth-inhibitory phenotype (GIP)” for reduced colony formation or reduced colony size upon IPTG-induced expression from the plasmid, “GIP-associated region” for a fragment that still produces the GIP when expressed, and “growth-escape mutant (GEM)” for a variant that no longer produces such a phenotype. None of these terms implies that the corresponding region, residue, or substitution is required for the native biological function of the human protein; establishing that would require an independent activity assay and validation in a eukaryotic context.</p><p>To test if human \"dark proteins\" produce a GIP in <i>E. coli</i>, we screened 29 human dark proteins through a three-phase BGIS pipeline <b>(Fig. 1A)</b>. In Phase 1, each protein was expressed as a GST fusion in <i>E. coli</i> BL21(DE3) and assessed for growth inhibition upon IPTG induction, using GST alone as a negative control and the DEK oncoprotein as a positive control (Guo, Prell, et al., 2021). Growth inhibition was defined as either complete absence of colony formation or a significant reduction in colony size on inducing plates relative to non-inducing controls (Fig. 1D), identifying candidates that produce a detectable growth-inhibitory phenotype (GIP). Proteins that produced the growth-inhibitory phenotype were carried into Phase 2, where AlphaFold2-predicted structural boundaries guided the design of protein fragments <b>(Fig. 1D)</b>, allowing the growth-inhibitory phenotype to be localized to a defined region without relying on experimental structural data. In Phase 3, the inhibitory domain was subjected to error-prone PCR mutagenesis to generate random variant libraries; colonies that escaped growth inhibition were then selected as candidate growth-escape mutants, with confirmed missense substitutions identified by sequencing.</p><p><a>Of the 29 dark proteins screened in Phase 1, eight exhibited complete or partial growth inhibition upon IPTG induction </a><b><a>(Fig. 1B)</a></b><a>, indicating that while BGIS is not universally applicable, a meaningful fraction of dark proteins produces a growth-inhibitory phenotype detectable by this approach. In Phase 2, </a>AlphaFold2-guided fragmentation localized the growth-inhibitory phenotype to a defined region in 6 of these proteins (<b>Fig. 1C</b>), supporting the utility of structure-predicted boundaries as a fragmentation strategy. To demonstrate the complete three-phase workflow, PBDC1 was taken through Phase 3 as a proof-of-concept example <b>(Fig. 1D–1E)</b>. Phase 2 fragmentation revealed that both region 1 and region 2 of PBDC1 independently retained the growth-inhibitory phenotype, with region 1 producing complete inhibition and Region 2 producing partial inhibition <b>(Fig. 1D)</b>. Error-prone PCR mutagenesis was performed on both regions; however, only region 2 yielded candidate growth-escape mutants after sequencing-based filtering to exclude nonsense and frameshift variants. Three variants carrying missense substitutions were identified in region 2, each carrying 2-3 amino acid substitutions, identifying residues that are associated with the growth-inhibitory phenotype in PBDC1 (<b>Fig. 1E</b>). These variants are candidates only: they have not been re-tested, and their relevance to the native biological function of PBDC1 has not been established.</p><p>Together, the screening of 29 human dark proteins, including phenotype-level mapping of the regions responsible for reduced growth in 6 of them, offers a preliminary reference that may serve as an entry point for future investigations into these uncharacterized proteins. For PBDC1 specifically, Phase 2 fragmentation and Phase 3 mutagenesis further yielded three candidate growth-escape variants in region 2, identifying residues associated with the phenotype and providing starting points for future mechanistic investigation. Moreover, the successful application of BGIS to human dark proteins serves as a proof-of-concept of a fast, low-cost workflow that requires no prior functional assumptions. While not universally applicable, this approach offers a practical methodology for researchers encountering bottlenecks in the phenotypic characterization of uncharacterized proteins and in the generation of variants that escape a given phenotype.</p><p>Several caveats and limitations should be noted. First, the mechanism underlying growth inhibition has not been experimentally verified for each dark protein screened; unlike DEK, whose toxicity was linked to direct DNA compaction (Guo, Prell, et al., 2021). Thus, the basis of inhibition in other candidates remains unknown, and growth inhibition alone cannot be taken as evidence of any particular molecular activity, nor of the protein's native biological function, in a eukaryotic context. Second, the AlphaFold2-guided fragmentation strategy relies on empirical identification of structural boundaries based on the visual clustering of secondary structure elements, which is subjective and may not correspond to genuine structural or functional boundaries. The reliability of this approach is further constrained by regional variations in AlphaFold2 prediction confidence (pLDDT scores), particularly in intrinsically disordered regions where boundary assignments are less certain. Third, the screen covers 29 proteins, and conclusions regarding the broader applicability of BGIS to the dark proteome should be interpreted with caution.<a> </a>Fourth, the error-prone PCR mutagenesis condition requires further optimization. The MnCl₂ concentration, the primary determinant of mutation load, proved difficult to control in practice: high concentrations introduced multiple substitutions per clone rather than the ideal single missense mutation, making it laborious to determine the key substitution responsible for escape from the phenotype. On the other hand, concentrations that were low failed to yield enough validated missense mutants because of a high proportion of nonsense mutations; a limitation particularly pronounced for Region 1 of PBDC1.</p><p>Finally, the candidate growth-escape mutants identified here have not been subjected to reversion mutagenesis, nor have the confirmed substitutions been reintroduced into full-length PBDC1 and re-expressed in <i>E. coli</i> to verify their effect in the intact protein context. As all validations were performed solely at the bacterial level, whether these substitutions affect the native biological function of PBDC1 in a eukaryotic context also remains to be determined. Future studies could perform reversion mutagenesis to define the minimal set of substitutions required to escape the phenotype, reintroducing confirmed mutations into full-length PBDC1 for bacterial re-expression, and ultimately characterizing these proteins and their growth-escape variants in human cells to obtain eukaryotic context information.</p>","references":[{"reference":"<p>Brannigan JA, Wilkinson AJ. 2002. Protein engineering 20 years on. Nature Reviews Molecular Cell Biology 3: 964-970.</p>","pubmedId":"","doi":"10.1038/nrm975"},{"reference":"<p>Cao X, Sun S, Xing J. 2024. A Massive Proteogenomic Screen Identifies Thousands of Novel Peptides From the Human “Dark” Proteome. Molecular &amp; Cellular Proteomics 23: 100719.</p>","pubmedId":"","doi":"10.1016/j.mcpro.2024.100719"},{"reference":"<p>Guo H, Prell M, Königs H, Xu N, Waldmann T, Hermans‐Sachweh B, et al., Kappes. 2021. Bacterial Growth Inhibition Screen (BGIS) identifies a loss‐of‐function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin. FEBS Letters 595: 1438-1453.</p>","pubmedId":"","doi":"10.1002/1873-3468.14070"},{"reference":"<p>Guo H, Xu N, Prell M, Königs H, Hermanns‐Sachweh B, Lüscher B, Kappes F. 2021. Bacterial Growth Inhibition Screen (BGIS): harnessing recombinant protein toxicity for rapid and unbiased interrogation of protein function. FEBS Letters 595: 1422-1437.</p>","pubmedId":"","doi":"10.1002/1873-3468.14072"},{"reference":"<p>Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al., Hassabis. 2021. Highly accurate protein structure prediction with AlphaFold. Nature 596: 583-589.</p>","pubmedId":"","doi":"10.1038/s41586-021-03819-2"},{"reference":"<p>Kelleher KJ, Sheils TK, Mathias SL, Yang JJ, Metzger VT, Siramshetty VB, et al., Oprea. 2022. Pharos 2023: an integrated resource for the understudied human proteome. Nucleic Acids Research 51: D1405-D1416.</p>","pubmedId":"","doi":"10.1093/nar/gkac1033"},{"reference":"<p>Moitra T, Larrouy-Maumus G. 2026. Integrated approaches for discovery and functional annotation of proteins of unknown function. Trends in Biochemical Sciences 51: 80-92.</p>","pubmedId":"","doi":"10.1016/j.tibs.2025.11.001"},{"reference":"<p>Nurk S, Koren S, Rhie A, Rautiainen M, Bzikadze AV, Mikheenko A, et al., Phillippy. 2022. The complete sequence of a human genome. Science 376: 44-53.</p>","pubmedId":"","doi":"10.1126/science.abj6987"},{"reference":"<p>Omenn GS, Orchard S, Lane L, Lindskog C, Pineau C, Overall CM, et al., Deutsch. 2024. The 2024 Report on the Human Proteome from the HUPO Human Proteome Project. Journal of Proteome Research 23: 5296-5311.</p>","pubmedId":"","doi":"10.1021/acs.jproteome.4c00776"},{"reference":"<p>Rocha JoJ, Jayaram SA, Stevens TJ, Muschalik N, Shah RD, Emran S, et al., Munro. 2023. Functional unknomics: Systematic screening of conserved genes of unknown function. PLOS Biology 21: e3002222.</p>","pubmedId":"","doi":"10.1371/journal.pbio.3002222"},{"reference":"<p>Sharifi Tabar M, Parsania C, Chen H, Su XD, Bailey CG, Rasko JEJ. 2022. Illuminating the dark protein-protein interactome. Cell Reports Methods 2: 100275.</p>","pubmedId":"","doi":"10.1016/j.crmeth.2022.100275"}],"title":"<p>Bacterial Growth Inhibition Screen (BGIS): an unconventional phenotype-based workflow for mapping regions in human dark proteins associated with reduced growth in <i>E. coli.</i></p>","reviews":[],"curatorReviews":[]},{"id":"e6f19ad5-29a0-44e9-bf44-0cab80dc30b4","decision":"publish","abstract":"<p>The human proteome holds immense therapeutic potential, yet many \"dark\" proteins remain functionally uncharacterized. We apply the Bacterial Growth Inhibition Screen (BGIS), previously validated on the DEK oncoprotein, to 29 dark human proteins. Through a three-phase screening pipeline comprising an initial growth-inhibition screen, AlphaFold-guided fragmentation, and error-prone PCR mutagenesis, BGIS identified regions associated with a growth-inhibitory phenotype in 8 of 29 proteins and, as exemplified by PBDC1, yielded candidate growth-escape mutants. This proof-of-concept study establishes BGIS as a scalable, cost-effective framework for preliminary hypothesis-independent, phenotype-level characterization of dark proteins, providing an additional experimental entry point for dark proteome research.</p>","acknowledgements":"","authors":[{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":[""],"credit":["conceptualization","dataCuration","formalAnalysis","fundingAcquisition","investigation","methodology","validation","visualization","writing_originalDraft","writing_reviewEditing"],"email":"songhe.jin@dukekunshan.edu.cn","firstName":"Songhe ","lastName":"Jin","submittingAuthor":false,"correspondingAuthor":false,"equalContribution":false,"WBId":null,"orcid":null},{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":[""],"credit":["conceptualization","dataCuration","formalAnalysis","fundingAcquisition","investigation","methodology","validation","writing_originalDraft","writing_reviewEditing"],"email":"chutian.chen@duke.edu","firstName":"Chutian ","lastName":"Chen ","submittingAuthor":false,"correspondingAuthor":false,"equalContribution":false,"WBId":null,"orcid":null},{"affiliations":["Xi'an Jiaotong-Liverpool University, Wuzhong District, Suzhou, China"],"departments":["Department of Biosciences and Bioinformatics"],"credit":["conceptualization","supervision","visualization","methodology"],"email":"yewei.liu@dukekunshan.edu.cn","firstName":"Yewei ","lastName":"Liu ","submittingAuthor":false,"correspondingAuthor":true,"equalContribution":true,"WBId":null,"orcid":"0009-0006-5666-1977"},{"affiliations":["Duke Kunshan University, Kunshan, JS, China"],"departments":["Division of Natural and Applied Sciences"],"credit":["conceptualization","fundingAcquisition","supervision","resources","writing_reviewEditing"],"email":"Ferdinand.Kappes@dukekunshan.edu.cn","firstName":"Ferdinand","lastName":"Kappes","submittingAuthor":true,"correspondingAuthor":true,"equalContribution":true,"WBId":null,"orcid":"0000-0002-0369-0065"}],"awards":[],"conflictsOfInterest":"<p>The authors declare that there are no conflicts of interest present.</p>","dataTable":{"url":null},"extendedData":[{"description":"<p>Extended Data 1. Images of BGIS experiments supporting the screening results shown in Fig. 1B–C.</p><p>(A) Representative BGIS results of the 29 selected human dark proteins. Each protein was transformed into E. coli BL21(DE3) and plated on LB-AMP plates with (+IPTG) or without (−IPTG) IPTG induction. Growth inhibition was evaluated by comparing colony formation between induced and non-induced conditions. Among the 29 proteins screened, CAAP1, MSANTD7, and DNAJC28 exhibited a complete growth inhibition phenotype, whereas PBDC1, PPAN-P2RY11, TMX3, EVA1C, and STKLD1 exhibited a partial growth inhibition phenotype upon IPTG induction. &nbsp;(B) Representative BGIS results of protein fragments derived from the inhibitory proteins identified in (A). Protein fragments were generated based on AlphaFold2-predicted structural boundaries and screened using BGIS to localize domain-specific growth inhibition activity.</p>","doi":"10.22002/yrmf4-jre15","resourceType":"Dataset","name":"Ex 1.jpg","url":"https://portal.micropublication.org/uploads/9739f2baa6fc8dfcac40564fd54d8817.jpg"},{"description":"<p>Extended Data 2. Expression analysis of all 29 human dark proteins used in this study via western blotting.</p>","doi":"10.22002/nmqzn-p5719","resourceType":"Dataset","name":"Ex2 (1).jpg","url":"https://portal.micropublication.org/uploads/fa3146d00d2f877fc199dd7888b13083.jpg"}],"funding":"<p>This work was supported by internal funding from Duke Kunshan University, including the Summer Research Scholarship (SRS), Signature Work Fund (SF), Signature Work Research Grant (SWRG), a grant from the DKU Innovation Incubator (Dii), and a Start-up Fund.</p>","image":{"url":"https://portal.micropublication.org/uploads/280048cc4c1fd5c6e7dca8ae72cf59fe.jpg"},"imageCaption":"<p><b>(A) BGIS workflow. </b>Phase 1, Initial BGIS: full-length dark proteins are expressed as GST fusions in <i>E. coli</i> BL21(DE3) and screened for the growth-inhibitory phenotype (GIP) upon IPTG induction. Phase 2, Domain Specific BGIS: inhibitory proteins are fragmented along AlphaFold2-predicted structural boundaries and re-screened to localize the region associated with the GIP. Phase 3, Growth-escape mutant screen: the fragment producing the GIP is mutagenized by error-prone PCR and screened for variants capable of escape. <b>(B)</b> <b>Summary table of all 29 dark proteins screened in Phase 1.</b> PubMed scores are sourced from the Pharos/TCRD database, reflecting the limited literature representation of these dark protein candidates. Detailed selection criteria are described in the Methods section. Proteins whose induced expression produces a complete or partial GIP are highlighted in blue, whereas; proteins that do not produce a GIP are not highlighted. Full plate images are shown in Extended Data Fig. 1A<b>. (C) Summary of BGIS results for all proteins producing a growth-inhibitory phenotype and their fragments from Phases 1 and 2.</b> A complete GIP (marked as \"complete\") indicates no colony formation on +IPTG plates; a partial GIP (marked as \"partial\") indicates significantly reduced colony size on +IPTG plates relative to −IPTG controls. Full plate images are shown in Extended Data Fig. 1B. <b>(D-E)</b> <b>Proof-of-concept demonstration using PBDC1. (D) BGIS results of PBDC1, its fragmentations, and error-prone PCR mutagenesis.</b> GST empty vector and GST-DEK fusion protein served as negative and positive controls respectively. Colony plate images show BGIS results for full-length PBDC1 and its AlphaFold-guided fragments (Region 1 and Region 2), where IPTG induction drives expression of the corresponding GST-fusion protein cloned into pGEX-4T-1. Error-prone PCR (EP) was performed at two MnCl₂ concentrations 0.3% (w/v) (EP 0.3%) and 0.5% (w/v) (EP 0.5%), the resulting mutant libraries were transformed into <i>E. coli</i> BL21(DE3). Large colonies emerging on +IPTG plates represent candidate growth-escape mutants that no longer produce the growth-inhibitory phenotype and were selected for sequencing. <b>(E) Candidate growth-escape mutants in PBDC1 Region 2. </b>After excluding sequences containing indels or nonsense mutations, remaining sequences were further filtered to retain only those harboring missense mutations, discarding synonymous substitutions. The resulting nucleotide changes and corresponding amino acid substitutions are indicated. Three candidate growth-escape mutants were identified in PBDC1 Region 2. These variants have not been re-tested, and their relevance to the native biological function of PBDC1 has not been established.</p>","imageTitle":"<p>Bacterial Growth Inhibition Screen (BGIS) of 29 human dark proteins identifies regions associated with a reduced growth phenotype in <i>E. coli</i> and growth-escape mutants in PBDC1</p>","methods":"<p><b>Protein Selection and Plasmid Construction</b></p><p><a>Candidate proteins were selected using the Target Development Level (TDL) classification in Pharos/TCRD </a>(Kelleher et al., 2023), focusing on proteins categorized as Tdark or low-confidence Tbio; tiers representing the least characterized fraction of the human proteome. Candidates were further filtered by two criteria: (i) the presence of at least one structurally discrete domain, as assessed by visual inspection of AlphaFold-predicted models (Jumper et al., 2021), and (ii) a Pharos PubMed Score below 50 —<b> </b>a conservative threshold well below well-studied and early-stage research targets (e.g., EGFR: 19,716; LRRK2: 2,119; DEK: 370) - indicating minimal direct representation in the biomedical literature <b>(Fig. 1B)</b>.</p><p>Additionally, three proteins absent from the Pharos/TCRD database were included as supplementary candidates to broaden the coverage of understudied targets. A0A1W2PQ72 (MSANTD7) is a reviewed Swiss-Prot entry with a UniProt annotation score of 2/5, reflecting near-absent experimental characterization. A6NDF3 (PBDC1) is an unreviewed TrEMBL entry with an annotation score of 1/5, but notably carries \"Evidence at protein level\", confirming experimental detection while remaining entirely without functional annotation. A0A0A6YYI3 (PPAN-P2RY11) is unreviewed with an annotation score of 1/5 and protein existence classified as \"Predicted\", indicating no experimental evidence for its expression or function.</p><p>Coding sequences were codon-optimized for <i>E. coli</i> BL21 (DE3) expression using the IDT Codon Optimization Tool and synthesized by GenScript. Each fragment was cloned into pGEX-4T-1 (GenScript) between the EcoRI and XhoI restriction sites, enabling IPTG-inducible expression as an N-terminal GST fusion protein. Correct insertion was confirmed by Sanger sequencing prior to use.</p><p><b>Bacterial Growth Inhibition Screen (BGIS)</b></p><p>LB agar was prepared at 40 g/L, autoclaved at 121 °C for 20 min, and supplemented with ampicillin (100 μg/mL) at ~50 °C. For BGIS plates, IPTG was additionally added to 0.1 mM at ~40 °C. Plates were dried in a biosafety cabinet and stored at 4 °C until use.</p><p>All plasmids were diluted to 10 ng/μL in nuclease-free water. Chemically competent <i>E. coli</i> BL21(DE3) cells (50 μL) were incubated with 1 μL plasmid on ice for 20 min, heat-shocked at 42 °C for 45 s, returned to ice for 5 min, and recovered in 70 μL LB for 5 min. Equal volumes (50 μL) of transformed culture were spread onto paired LB-AMP plates with and without 0.1 mM IPTG and incubated at 37 °C overnight. Colony formation was compared between conditions and proteins were classified as producing \"complete inhibition,\" \"partial inhibition,\" or \"no inhibition\" of colony formation upon induced expression. This classification is purely phenotypic: it reports growth on solid medium and does not identify a molecular activity of the expressed protein. The empty pGEX-4T-1 vector (GST alone) served as the negative control; a GST-DEK fusion protein served as the positive control (Guo et al., 2021). All BGIS analyses were carried out in triplicate, and the results were reproducible across all replicates.</p><p><b>Protein Expression and Western Blotting (Extended Data Fig. 2)</b></p><p>Single colonies were inoculated into 5 mL LB-AMP and grown overnight at 37 °C. The following day, 1 mL of overnight culture was diluted into 4 mL LB-AMP and incubated at 37 °C for 2 h. The culture was divided into two 1.5 mL aliquots; one was supplemented with 0.1 mM IPTG and both were incubated for a further 1.5 h at 37 °C.</p><p>Cells were pelleted at 8,000 rpm (6,080 × g) for 1 min, resuspended in 100 μL 2% SDS, 40% power ultrasonic disrupted (SCIENTZ Ultrasonic Homogenizer JY96-IIN) for 3-5 seconds until the solution lost its viscosity. 12 μL of lysate was combined with 3 μL 5× Laemmli Sample buffer, heated at 95 °C for 5 min, and resolved by SDS-PAGE on 10% polyacrylamide gels at 80 V (stacking) then 120 V (resolving). Proteins were transferred to PVDF membrane by semi-dry transfer at 100 mA for 75 min. After blocking with 5% skim milk in TBST, membranes were probed overnight at 4 °C with an anti-GST rabbit monoclonal antibody (1:1,000; Beyotime), washed three times in TBST, then incubated with HRP-conjugated goat anti-rabbit IgG (1:10,000; Beyotime) for 60 min at room temperature. Signal was detected by chemiluminescence (Cytiva, ImageQuant 800) and images were quantified using ImageJ.</p><p><b>AlphaFold-Guided Protein Fragmentation and Subcloning</b></p><p>Proteins that produced the growth-inhibitory phenotype were fragmented for phenotype-level mapping. Boundaries were determined from AlphaFold2-predicted structures and per-residue confidence (pLDDT) scores (https://alphafold.ebi.ac.uk/): domain interfaces were used where clear tertiary boundaries existed, and transitions from low (yellow) to very low (orange) pLDDT were used otherwise. Fragments were designed to span 80–200 amino acids.</p><p>Primers were designed with target T<sub>m</sub> of 51–56 °C and GC content of 40–60%, adding restriction enzyme cleavage site,and verified by BLAST against the constructed full length protein’s plasmid sequence. PCR was performed in 50 μL reaction system (Reagent.Table 3) with the following cycling conditions: 95 °C for 3 min; 33 cycles of 95 °C for 30 s, 56 °C for 30 s, 72 °C for 1min; final extension at 72 °C for 5 min; hold at 12 °C. Products were resolved on 1% agarose gels containing Gel Red Nucleic Acid (Adamas Life) at 120 V for 30 min, and bands of correct size were excised and purified using the QIAGEN QIAquick Gel Extraction Kit (eluted in 30 μL nuclease-free water).</p><p>Gel-purified fragments and the pGEX-4T-1 vector were digested with EcoRI and XhoI (Reagent. Table 4). For inserts containing an internal EcoRI site (e.g., protein 159), SalI was substituted for EcoRI. Digested products were column-purified prior to ligation. Ligation was carried out in a 20 μL reaction containing insertion sequence and linearized vector at a 3:1 molar ratio, 1× T4 DNA Ligase buffer, and T4 DNA Ligase (Beyotime) (Reagent. Table 5), incubated at 25 °C for 2 h or 16 °C overnight. 10 μL of ligation product was transformed into DH5α competent cells using the same heat-shock protocol described above and plated on LB-AMP agar. Colonies were screened by Sanger sequencing (Sangon Biotech, Suzhou), and verified constructs were propagated in DH5α, extracted by miniprep (QI Aprep Spin Miniprep Kit), and retransformed into BL21(DE3) for secondary BGIS.</p><p><b>Error-Prone PCR Mutagenesis</b></p><p>To generate libraries of candidate growth-escape mutants, error-prone PCR was applied to the coding sequence of each fragment that produced the growth-inhibitory phenotype, introducing random mutations. Two MnCl<sub>2</sub> concentrations were used to modulate mutation frequency (Reagent. Table 6); all other conditions were identical to standard PCR. Amplified mutant mixture were gel-purified, digested, ligated into pGEX-4T-1, and transformed into BL21(DE3) as described above. Transformants were plated on LB-AMP-IPTG plates and incubated overnight at 37 °C.</p><p>Because all selected proteins either completely or partially inhibit <i>E. coli</i> growth upon induction, colonies on +IPTG plates that carried mutated variants were visibly larger than background microcolonies, indicative of a variant that no longer produces the growth-inhibitory phenotype upon induced expression. They were designated candidate growth-escape mutants (GEMs).</p><p><b><a>Sanger Sequencing and Identification of Growth-Escape Mutants</a></b></p><p>Large colonies from +IPTG plates were picked and their plasmids extracted for Sanger sequencing (Sangon Biotech, Suzhou). Sequences were aligned to the wild-type reference using SnapGene to identify all nucleotide changes relative to the wild-type coding sequence.</p><p>Candidate sequences were then filtered using the following criteria to isolate informative growth-escape variants. First, sequences containing any insertion or deletion were excluded, as frameshift mutations would globally disrupt protein structure and preclude attribution of the phenotype to particular residues. Second, sequences harboring premature stop codons (nonsense mutations) were excluded for the same reason—truncated proteins cannot be used to reliably attribute escape from the phenotype to a specific region or residue. Third, synonymous substitutions—single-nucleotide changes that do not alter the encoded amino acid (silent mutations)—were also excluded, as they are unlikely to contribute to escape from the observed growth-inhibitory phenotype. Only sequences carrying non-synonymous single-nucleotide substitutions (missense mutations) were retained as candidate growth-escape variants.</p>","reagents":"<p>Table 1. Bacterial Strains</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Strains</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p><i>E. coli</i> BL21(DE3)pLysS</p></td><td><p>AngyuBio</p></td></tr><tr><td><p><i>E. coli</i> DH5α</p></td><td><p>AngyuBio</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 2. Plasmids</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Plasmids</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p>pGEX-4T-1</p></td><td><p>Genescript</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 3. PCR reaction system (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Final Concentration</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>to 50</p></td><td><p>—</p></td></tr><tr><td><p>10× BeyoTaq Buffer with Mg<sup>2+</sup> (Beyotime, #D7020-2)</p></td><td><p>5</p></td><td><p>1×</p></td></tr><tr><td><p>dNTP mixture (25mM) (Beyotime, #D7371 )</p></td><td><p>0.4</p></td><td><p>0.2 mM</p></td></tr><tr><td><p>Primer Forward (10 μM)</p></td><td><p>2</p></td><td><p>0.4 μM</p></td></tr><tr><td><p>Primer Reverse (10 μM)</p></td><td><p>2</p></td><td><p>0.4 μM</p></td></tr><tr><td><p>Template plasmid</p></td><td><p>—</p></td><td><p>[20 ng]</p></td></tr><tr><td><p>Beyo Taq DNA polymerase (5U/μL) (Beyotime, #D7219-1)</p></td><td><p>0.25</p></td><td><p>[1.25 U]</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 4. Restriction endonuclease digestion system (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>to 50</p></td></tr><tr><td><p>10× CutSmart buffer (New England Biolabs, #B6004S)</p></td><td><p>5</p></td></tr><tr><td><p>PCR product or vector</p></td><td><p>30</p></td></tr><tr><td><p>Restriction endonuclease</p><p>(XhoI: NEB, #R0146V; EcoRI: NEB, #R3101V)</p></td><td><p>1 each</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 5. T4 Ligation System.</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Volume (μL)</b></p></td></tr><tr><td><p>T4 DNA Ligase Buffer (NEB, #B0202S)</p></td><td><p>2</p></td></tr><tr><td><p>T4 DNA Ligase (Beyotime, #D7006-1)</p></td><td><p>0.5</p></td></tr><tr><td><p>Digested DNA Fragment (~30ng/μL)</p></td><td><p>2</p></td></tr><tr><td><p>Digested linear pGEX-4T-1 (~5ng/μL)</p></td><td><p>16</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 6. Error-prone PCR reaction systems (50 μL total volume).</p><table><tbody><tr><td style=\"background-color: rgb(221, 221, 221);\"><p><b>Component</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>0.3 % (w/v) MnCl₂ System (μL)</b></p></td><td style=\"background-color: rgb(221, 221, 221);\"><p><b>0.5 % (w/v) MnCl₂ System (μL)</b></p></td></tr><tr><td><p>Nuclease-free water</p></td><td><p>Up to 50</p></td><td><p>Up to 50</p></td></tr><tr><td><p>10× BeyoTaq Buffer with Mg<sup>2+</sup> (Beyotime, #D7020-2)</p></td><td><p>5</p></td><td><p>5</p></td></tr><tr><td><p>dNTP mixture (25mM) (Beyotime, #D7371 )</p></td><td><p>4</p></td><td><p>4</p></td></tr><tr><td><p>Template</p></td><td><p>1</p></td><td><p>1</p></td></tr><tr><td><p>Forward primer (10 μM)</p></td><td><p>2</p></td><td><p>2</p></td></tr><tr><td><p>Reverse primer (10 μM)</p></td><td><p>2</p></td><td><p>2</p></td></tr><tr><td><p>Beyo Taq DNA polymerase (5U/μL) (Beyotime, #D7219-1)</p></td><td><p>0.25</p></td><td><p>0.25</p></td></tr><tr><td><p>MnCl₂ 10% (w/v) stock</p></td><td><p>1.5</p></td><td><p>2.5</p></td></tr></tbody></table><p>&nbsp;</p><p>Table 7: Protein fragmentation primers</p><table><tbody><tr><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Primer_name</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Primer_seq</b></p></td><td style=\"background-color: rgb(217, 217, 217);\"><p><b>Supplier</b></p></td></tr><tr><td><p>Common_F</p></td><td><p>CAAAATCGGATCTGGTTCCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>Common_R</p></td><td><p>TCGTCAGTCAGTCACGATG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-1_R</p></td><td><p>TCACTCGAGCTCCAAGTCGCTGTGTTC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-2_F</p></td><td><p>TCAGAATTCGACTTGGAGGAAGGTGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-2_R</p></td><td><p>TCACTCGAGCTCCTCCATGTCCGAATCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>CAAP1-3_F</p></td><td><p>TCAGAATTCGAGGAGGAAGCGGATGATG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>DNAJC28-1_R</p></td><td><p>ACTCTCGAGTCACCTTTAGCCATGCTCTCCT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>DNAJC28-2_F</p></td><td><p>TCAGAATTCGGTGATTTCGATAACCTCTCCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-1_R</p></td><td><p>TCTCTCGAGTCTTCAGTTCATTCGGCTGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-2_F</p></td><td><p>TCAGAATTCGTGTCTTTTAAGTGCCAGCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-2_R</p></td><td><p>TCACTCGAGCGGCTTCAGGTTGGC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>EVA1C-3_F</p></td><td><p>TCAGAATTCGCGATCGCCAACCTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>MSANTD7-1_R</p></td><td><p>ACACTCGAGGCAACCAAGTTTTGATCGCAG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>MSANTD7-2_F</p></td><td><p>TCAGAATTCCACTGCGATCAAAACTTGGTT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PPAN-P2RY11-1_R</p></td><td><p>TCACTCGAGCTCTTCCTCAGTTTTGC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PPAN-P2RY11-2_F</p></td><td><p>TCAGAATTCGGCAAAGTGATGTTTCACTCG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>STKLD1-1_R</p></td><td><p>ACTCTCGAGCTGCCTCTCAGGAAGGTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>STKLD1-2_F</p></td><td><p>TCAGAATTCGGCAGTTTCAAGTCCAGTTG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-1_R</p></td><td><p>ACACTCGAGGAAGTGGCCGAATTAGAG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-2_F</p></td><td><p>ACAGAATTCCCACTTCCAAGTCAACAAATGT</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-2_R</p></td><td><p>ACACTCGAGAAACCTTTCCCTGTTGATCC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>TMX3-3_F</p></td><td><p>TCAGAATTCCAGAATTACCTTGCTATGGATGG</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PBDC1-1_R</p></td><td><p>TCACTCGAGCGTTTCTTCTCAACGGTC</p></td><td><p>Sangon Biotech</p></td></tr><tr><td><p>PBDC1-2_F</p></td><td><p>TCAGAATTCGTTGAGAAGAAACGTACCC</p></td><td><p>Sangon Biotech</p></td></tr></tbody></table>","patternDescription":"<p>Despite the Human Genome Project's identification of ~20,000 protein-coding genes (Nurk et al., 2022) and large-scale efforts such as the HUPO Human Proteome Project (Omenn et al., 2024), a substantial portion of the human proteome remains functionally unannotated, the so-called \"dark proteins\", whose activities and interactions have yet to be experimentally elucidated (Cao et al., 2024).</p><p>While recent studies highlighted that many “dark” proteins indeed execute essential functions in organisms (Moitra &amp; Larrouy-Maumus, 2026; Rocha et al., 2023),<a> research on “dark” proteins remains limited, often due to a lack of molecular tools and the labor-intensive nature of the work with uncertain rewards</a> (Sharifi Tabar et al., 2022). In addition, despite structural predictions by AlphaFold, experimentally deciphering molecular function at the domain level in dark proteins presents a methodological challenge. A critical step in such studies is the generation of mutants that reduce or abolish a defined protein activity, which in turn allows that activity to be linked causally to a cellular phenotype, rather than relying solely on gene-level knockdown or knockout approaches that abolish all protein functions simultaneously (Guo, Prell, et al., 2021). Conventional site-directed mutagenesis is the standard strategy for generating such mutants; however, it requires detailed prior knowledge of protein structure and functionally important residues (Brannigan &amp; Wilkinson, 2002). For dark proteins, this information is typically unavailable.&nbsp;</p><p>Therefore, for dark proteins lacking any such prior information, an unbiased, hypothesis-independent approach to identifying the regions of a protein that produce a measurable phenotype, and to generating variants that escape that phenotype, is required.<a> To address this challenge, Guo et al. (2021) established the Bacterial Growth Inhibition Screen (BGIS) for the study of proteins.</a> Using this strategy, we previously identified a mutant of the DEK oncoprotein that no longer produces a growth-inhibitory phenotype; for DEK, this phenotype has been linked to direct DNA compaction. These results demonstrate that, in a protein for which an independent activity assay exists, BGIS can point to residues relevant to a defined molecular activity in a fully hypothesis-independent manner (Guo, Prell, et al., 2021; Guo, Xu, et al., 2021).</p><p>However, BGIS has only been validated on protein (DEK) with known functions, and its applicability to dark proteins, where no functional or structural reference exists, remains unexplored. One barrier lies in domain fragmentation: localizing the growth-inhibitory phenotype to a specific region of a full-length protein requires rational boundaries for fragmentation, information that is unavailable for dark proteins. The release of AlphaFold2, which provides relatively high-confidence structural predictions for protein sequences, offers a solution to this problem by enabling structure-guided fragmentation without experimental structural data. In this study, we integrate BGIS with AlphaFold2-predicted domain boundaries to systematically screen human dark proteins for the growth-inhibitory phenotype, to localize the regions associated with it, and to generate candidate growth-escape mutants, establishing a proof-of-concept workflow for hypothesis-independent, phenotype-level characterization of the dark proteome.</p><p>Throughout this manuscript we use “phenotype” in a strict, operational sense. Heterologous overexpression of a non-native protein in <i>E. coli</i> can reduce growth for reasons that are unrelated to the protein's native biological function, including protein misfolding, aggregation, or other effects. We therefore do not directly equate reduced growth with molecular activity, and we do not infer native function from these experiments. Accordingly, we use “growth-inhibitory phenotype (GIP)” for reduced colony formation or reduced colony size upon IPTG-induced expression from the plasmid, “GIP-associated region” for a fragment that still produces the GIP when expressed, and “growth-escape mutant (GEM)” for a variant that no longer produces such a phenotype. None of these terms implies that the corresponding region, residue, or substitution is required for the native biological function of the human protein; establishing that would require an independent activity assay and validation in a eukaryotic context.</p><p>To test if human \"dark proteins\" produce a GIP in <i>E. coli</i>, we screened 29 human dark proteins through a three-phase BGIS pipeline <b>(Fig. 1A)</b>. In Phase 1, each protein was expressed as a GST fusion in <i>E. coli</i> BL21(DE3) and assessed for growth inhibition upon IPTG induction, using GST alone as a negative control and the DEK oncoprotein as a positive control (Guo, Prell, et al., 2021). Growth inhibition was defined as either complete absence of colony formation or a significant reduction in colony size on inducing plates relative to non-inducing controls (Fig. 1D), identifying candidates that produce a detectable growth-inhibitory phenotype (GIP). Proteins that produced the growth-inhibitory phenotype were carried into Phase 2, where AlphaFold2-predicted structural boundaries guided the design of protein fragments <b>(Fig. 1D)</b>, allowing the growth-inhibitory phenotype to be localized to a defined region without relying on experimental structural data. In Phase 3, the inhibitory domain was subjected to error-prone PCR mutagenesis to generate random variant libraries; colonies that escaped growth inhibition were then selected as candidate growth-escape mutants, with confirmed missense substitutions identified by sequencing.</p><p><a>Of the 29 dark proteins screened in Phase 1, eight exhibited complete or partial growth inhibition upon IPTG induction </a><b><a>(Fig. 1B)</a></b><a>, indicating that while BGIS is not universally applicable, a meaningful fraction of dark proteins produces a growth-inhibitory phenotype detectable by this approach. In Phase 2, </a>AlphaFold2-guided fragmentation localized the growth-inhibitory phenotype to a defined region in 6 of these proteins (<b>Fig. 1C</b>), supporting the utility of structure-predicted boundaries as a fragmentation strategy. To demonstrate the complete three-phase workflow, PBDC1 was taken through Phase 3 as a proof-of-concept example <b>(Fig. 1D–1E)</b>. Phase 2 fragmentation revealed that both region 1 and region 2 of PBDC1 independently retained the growth-inhibitory phenotype, with region 1 producing complete inhibition and Region 2 producing partial inhibition <b>(Fig. 1D)</b>. Error-prone PCR mutagenesis was performed on both regions; however, only region 2 yielded candidate growth-escape mutants after sequencing-based filtering to exclude nonsense and frameshift variants. Three variants carrying missense substitutions were identified in region 2, each carrying 2-3 amino acid substitutions, identifying residues that are associated with the growth-inhibitory phenotype in PBDC1 (<b>Fig. 1E</b>). These variants are candidates only: they have not been re-tested, and their relevance to the native biological function of PBDC1 has not been established.</p><p>Together, the screening of 29 human dark proteins, including phenotype-level mapping of the regions responsible for reduced growth in 6 of them, offers a preliminary reference that may serve as an entry point for future investigations into these uncharacterized proteins. For PBDC1 specifically, Phase 2 fragmentation and Phase 3 mutagenesis further yielded three candidate growth-escape variants in region 2, identifying residues associated with the phenotype and providing starting points for future mechanistic investigation. Moreover, the successful application of BGIS to human dark proteins serves as a proof-of-concept of a fast, low-cost workflow that requires no prior functional assumptions. While not universally applicable, this approach offers a practical methodology for researchers encountering bottlenecks in the phenotypic characterization of uncharacterized proteins and in the generation of variants that escape a given phenotype.</p><p>Several caveats and limitations should be noted. First, the mechanism underlying growth inhibition has not been experimentally verified for each dark protein screened; unlike DEK, whose toxicity was linked to direct DNA compaction (Guo, Prell, et al., 2021). Thus, the basis of inhibition in other candidates remains unknown, and growth inhibition alone cannot be taken as evidence of any particular molecular activity, nor of the protein's native biological function, in a eukaryotic context. Second, the AlphaFold2-guided fragmentation strategy relies on empirical identification of structural boundaries based on the visual clustering of secondary structure elements, which is subjective and may not correspond to genuine structural or functional boundaries. The reliability of this approach is further constrained by regional variations in AlphaFold2 prediction confidence (pLDDT scores), particularly in intrinsically disordered regions where boundary assignments are less certain. Third, the screen covers 29 proteins, and conclusions regarding the broader applicability of BGIS to the dark proteome should be interpreted with caution.<a> </a>Fourth, the error-prone PCR mutagenesis condition requires further optimization. The MnCl₂ concentration, the primary determinant of mutation load, proved difficult to control in practice: high concentrations introduced multiple substitutions per clone rather than the ideal single missense mutation, making it laborious to determine the key substitution responsible for escape from the phenotype. On the other hand, concentrations that were low failed to yield enough validated missense mutants because of a high proportion of nonsense mutations; a limitation particularly pronounced for Region 1 of PBDC1.</p><p>Finally, the candidate growth-escape mutants identified here have not been subjected to reversion mutagenesis, nor have the confirmed substitutions been reintroduced into full-length PBDC1 and re-expressed in <i>E. coli</i> to verify their effect in the intact protein context. As all validations were performed solely at the bacterial level, whether these substitutions affect the native biological function of PBDC1 in a eukaryotic context also remains to be determined. Future studies could perform reversion mutagenesis to define the minimal set of substitutions required to escape the phenotype, reintroducing confirmed mutations into full-length PBDC1 for bacterial re-expression, and ultimately characterizing these proteins and their growth-escape variants in human cells to obtain eukaryotic context information.</p>","references":[{"reference":"<p>Brannigan JA, Wilkinson AJ. 2002. Protein engineering 20 years on. Nature Reviews Molecular Cell Biology 3: 964-970.</p>","pubmedId":"","doi":"10.1038/nrm975"},{"reference":"<p>Cao X, Sun S, Xing J. 2024. A Massive Proteogenomic Screen Identifies Thousands of Novel Peptides From the Human “Dark” Proteome. Molecular &amp; Cellular Proteomics 23: 100719.</p>","pubmedId":"","doi":"10.1016/j.mcpro.2024.100719"},{"reference":"<p>Guo H, Prell M, Königs H, Xu N, Waldmann T, Hermans‐Sachweh B, et al., Kappes. 2021. Bacterial Growth Inhibition Screen (BGIS) identifies a loss‐of‐function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin. FEBS Letters 595: 1438-1453.</p>","pubmedId":"","doi":"10.1002/1873-3468.14070"},{"reference":"<p>Guo H, Xu N, Prell M, Königs H, Hermanns‐Sachweh B, Lüscher B, Kappes F. 2021. Bacterial Growth Inhibition Screen (BGIS): harnessing recombinant protein toxicity for rapid and unbiased interrogation of protein function. FEBS Letters 595: 1422-1437.</p>","pubmedId":"","doi":"10.1002/1873-3468.14072"},{"reference":"<p>Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al., Hassabis. 2021. Highly accurate protein structure prediction with AlphaFold. Nature 596: 583-589.</p>","pubmedId":"","doi":"10.1038/s41586-021-03819-2"},{"reference":"<p>Kelleher KJ, Sheils TK, Mathias SL, Yang JJ, Metzger VT, Siramshetty VB, et al., Oprea. 2022. Pharos 2023: an integrated resource for the understudied human proteome. Nucleic Acids Research 51: D1405-D1416.</p>","pubmedId":"","doi":"10.1093/nar/gkac1033"},{"reference":"<p>Moitra T, Larrouy-Maumus G. 2026. Integrated approaches for discovery and functional annotation of proteins of unknown function. Trends in Biochemical Sciences 51: 80-92.</p>","pubmedId":"","doi":"10.1016/j.tibs.2025.11.001"},{"reference":"<p>Nurk S, Koren S, Rhie A, Rautiainen M, Bzikadze AV, Mikheenko A, et al., Phillippy. 2022. The complete sequence of a human genome. Science 376: 44-53.</p>","pubmedId":"","doi":"10.1126/science.abj6987"},{"reference":"<p>Omenn GS, Orchard S, Lane L, Lindskog C, Pineau C, Overall CM, et al., Deutsch. 2024. The 2024 Report on the Human Proteome from the HUPO Human Proteome Project. Journal of Proteome Research 23: 5296-5311.</p>","pubmedId":"","doi":"10.1021/acs.jproteome.4c00776"},{"reference":"<p>Rocha JoJ, Jayaram SA, Stevens TJ, Muschalik N, Shah RD, Emran S, et al., Munro. 2023. Functional unknomics: Systematic screening of conserved genes of unknown function. PLOS Biology 21: e3002222.</p>","pubmedId":"","doi":"10.1371/journal.pbio.3002222"},{"reference":"<p>Sharifi Tabar M, Parsania C, Chen H, Su XD, Bailey CG, Rasko JEJ. 2022. Illuminating the dark protein-protein interactome. Cell Reports Methods 2: 100275.</p>","pubmedId":"","doi":"10.1016/j.crmeth.2022.100275"}],"title":"<p>Bacterial Growth Inhibition Screen (BGIS): an unconventional phenotype-based workflow for mapping regions in human dark proteins associated with reduced growth in <i>E. coli.</i></p>","reviews":[],"curatorReviews":[]}]}},"species":{"species":[{"value":"acer saccharum","label":"Acer saccharum","imageSrc":"","imageAlt":"","mod":"TreeGenes","modLink":"https://treegenesdb.org","linkVariable":""},{"value":"achillea millefolium","label":"Achillea millefolium","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"acinetobacter baylyi","label":"Acinetobacter baylyi","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"actinobacteria bacterium","label":"Actinobacteria bacterium","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"adelges tsugae","label":"Adelges tsugae","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"adenocaulon chilense","label":"Adenocaulon chilense","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"aedes japonicus","label":"Aedes japonicus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"aegorhinus vitulus","label":"Aegorhinus vitulus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"aerococcus","label":"Aerococcus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"alaimidae","label":"Alaimidae","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"allobates femoralis","label":"Allobates femoralis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"alnus glutinosa","label":"Alnus glutinosa","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"alosa aestivalis","label":"Alosa aestivalis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"alosa pseudoharengus","label":"Alosa pseudoharengus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"alternaria alternata","label":"Alternaria alternata","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"amynthas agrestis","label":"Amynthas Agrestis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ancylostoma caninum","label":"Ancylostoma caninum","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ancylostoma ceylanicum","label":"Ancylostoma ceylanicum","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"anemone multifida","label":"Anemone multifida","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"anguilla rostrata","label":"Anguilla rostrata","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"anisakis simplex","label":"Anisakis simplex","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"anomala albopilosa","label":"Anomala albopilosa","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"anthomyiidae sp","label":"Anthomyiidae sp","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"anthomyiidae sp","label":"Anthomyiidae sp","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"arabidopsis","label":"Arabidopsis","imageSrc":"arabidopsis.png","imageAlt":"Arabidopsis graphic by Zoe Zorn CC BY 4.0","mod":"TAIR","modLink":"https://arabidopsis.org","linkVariable":""},{"value":"architeuthis dux","label":"Architeuthis dux","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"arion vulgaris","label":"Arion vulgaris","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"armeria","label":"Armeria","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"artemia","label":"Artemia","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"arthrobacter sp.","label":"Arthrobacter sp.","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ascaridia","label":"Ascaridia","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ascaridia galli","label":"Ascaridia galli","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"asparagopsis taxiformis","label":"Asparagopsis taxiformis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"astatotilapia burtoni","label":"Astatotilapia burtoni","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"avena sativa","label":"Avena sativa","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"aves","label":"Aves","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bacillus","label":"Bacillus (firmicutes)","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bacillus cereus","label":"Bacillus cereus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bacillus mycoides","label":"Bacillus mycoides","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bacillus subtilis","label":"Bacillus subtilis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bacillus thuringiensis","label":"Bacillus thuringiensis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bacillus toyonensis","label":"Bacillus toyonensis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bacillus wiedmannii","label":"Bacillus wiedmannii","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bacteria","label":"Bacteria","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bacteriophage","label":"Bacteriophage","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bactrocera","label":"Bactrocera sp.","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"batrachospermum gelatinosum","label":"Batrachospermum gelatinosum","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"betula lenta","label":"Betula lenta","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"betula nigra","label":"Betula nigra","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bombus dahlbohmii","label":"Bombus dahlbohmii","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bombus terrestris","label":"Bombus terrestris","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bombyx mori","label":"Bombyx mori","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bos taurus","label":"Bos Taurus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"brachygobius doriae","label":"Brachygobius doriae","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"brassica oleracea","label":"Brassica oleracea","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"brassica rapa","label":"Brassica rapa","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"brugia malayi","label":"Brugia malayi","imageSrc":"","imageAlt":"","mod":"WormBase","modLink":"www.wormbase.org","linkVariable":""},{"value":"burkholderia thailandensis","label":"Burkholderia thailandensis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"buttiauxella","label":"Buttiauxella","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"caenorhabditis brenneri","label":"Caenorhabditis brenneri","imageSrc":"","imageAlt":"","mod":"WormBase","modLink":"www.wormbase.org","linkVariable":""},{"value":"caenorhabditis briggsae","label":"Caenorhabditis briggsae","imageSrc":"","imageAlt":"","mod":"WormBase","modLink":"www.wormbase.org","linkVariable":""},{"value":"c. elegans","label":"Caenorhabditis elegans","imageSrc":"c-elegans.jpg","imageAlt":"C. elegans graphic by Zoe Zorn CC BY 4.0","mod":"WormBase","modLink":"https://wormbase.org","linkVariable":""},{"value":"caenorhabditis inopinata","label":"Caenorhabditis inopinata","imageSrc":"","imageAlt":"","mod":"WormBase","modLink":"www.wormbase.org","linkVariable":""},{"value":"caenorhabditis japonica","label":"Caenorhabditis japonica","imageSrc":"","imageAlt":"","mod":"WormBase","modLink":"www.wormbase.org","linkVariable":""},{"value":"caenorhabditis nigoni","label":"Caenorhabditis nigoni","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"caenorhabditis remanei","label":"Caenorhabditis remanei","imageSrc":"","imageAlt":"","mod":"WormBase","modLink":"www.wormbase.org","linkVariable":""},{"value":"caenorhabditis tropicalis","label":"Caenorhabditis tropicalis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"calidifontibacillus","label":"Calidifontibacillus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"calidifontibacillus erzuremensis","label":"Calidifontibacillus erzuremensis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"calliphora sp","label":"Calliphora sp","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"caltha sagittata","label":"Caltha sagittata","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"cambarus latimanus","label":"Cambarus latimanus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"candida albicans","label":"Candida albicans","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"canis familiaris","label":"Canis familiaris","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"cannabis sativa","label":"Cannabis sativa","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"caretta caretta","label":"Caretta caretta","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"cassiopea xamachana","label":"Cassiopea xamachana","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"caulobacter vibrioides","label":"Caulobacter vibrioides","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"cephalopods","label":"Cephalopoda","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"cerastium arvense","label":"Cerastium arvense","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ceriodaphnia","label":"Ceriodaphnia","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ceroglossus suturalis","label":"Ceroglossus suturalis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"chaetoceros","label":"Chaetoceros","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"chamaecrista fasciculata","label":"Chamaecrista fasciculata","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"chilicola chalcidiformis","label":"Chilicola chalcidiformis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"chitinimonas","label":"Chitinimonas","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"chlamydomonas reinhardtii","label":"Chlamydomonas reinhardtii","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"chromobacterium","label":"Chromobacterium","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"chrysemys picta","label":"Chrysemys picta","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"chrysoperla rufilabris","label":"Chrysoperla rufilabris","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"citrus","label":"Citrus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"clavibacter sp.","label":"Clavibacter sp.","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"colinus virginianus","label":"Colinus virginianus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"crassostrea virginica","label":"Crassostrea virginica","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"crithidia fasciculata","label":"Crithidia fasciculata","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"cutibacterium acnes","label":"Cutibacterium acnes","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"cyanobacteria","label":"Cyanobacteria","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"daphnia","label":"Daphnia","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"daphnia pulex","label":"Daphnia pulex","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"dermacoccus nishinomiyaensis","label":"Dermacoccus nishinomiyaensis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"diabrotica virgifera","label":"Diabrotica virgifera","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"diabrotica virgifera virgifera virus 1","label":"Diabrotica virgifera virgifera virus 1","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"d. discoideum","label":"Dictyostelium discoideum","imageSrc":"dicty.png","imageAlt":"D. discoideum","mod":"dictyBase","modLink":"http://dictybase.org","linkVariable":""},{"value":"diptera","label":"Diptera","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"dotocryptus bellicosus","label":"Dotocryptus bellicosus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"drechmeria coniospora","label":"Drechmeria coniospora","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"drosophila","label":"Drosophila","imageSrc":"drosophila.png","imageAlt":"Drosophila graphic by Zoe Zorn CC BY 4.0","mod":"FlyBase","modLink":"https://flybase.org/doi/","linkVariable":"doi"},{"value":"dryopteris campyloptera","label":"Dryopteris campyloptera","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"dryopteris expansa","label":"Dryopteris expansa","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"dryopteris intermedia","label":"Dryopteris intermedia","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"dugesia dorotocephala","label":"Dugesia dorotocephala","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"elasmobranchii","label":"Elasmobranchii","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"embryophyta","label":"Embryophyta","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"enoploteuthis chunii","label":"Enoploteuthis chunii","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"enterobacter aerogenes","label":"Enterobacter aerogenes","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"enterococcus raffinosus","label":"Enterococcus raffinosus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"epichloë coenophiala","label":"Epichloë coenophiala","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"equus caballus","label":"Equus caballus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"erigeron sp","label":"Erigeron sp","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"eristalis","label":"Eristalis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"eruca vesicaria","label":"Eruca vesicaria","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"erwinia carotovora","label":"Erwinia carotovora","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"erythronium americanum","label":"Erythronium americanum","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"escherichia coli","label":"Escherichia coli","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"eukaryota","label":"Eukaryotes","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"felis catus","label":"Felis catus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"francisella novicida","label":"Francisella novicida","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"francisella tularensis","label":"Francisella tularensis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"fraxinus americana","label":"Fraxinus americana","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"fucus distichus","label":"Fucus distichus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"fungi","label":"Fungi","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"gasteropelecus sp.","label":"Gasteropelecus sp.","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"geranium sp","label":"Geranium sp","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"girardia","label":"Girardia","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"glaucomys volans","label":"Glaucomys volans","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"glycine max","label":"Glycine max","imageSrc":"","imageAlt":"","mod":"Soybase","modLink":"https://soybase.org","linkVariable":""},{"value":"glyptemys insculpta","label":"Glyptemys insculpta","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"gossypium hirsutum","label":"Gossypium hirsutum","imageSrc":"","imageAlt":"","mod":"CottonGen","modLink":"https://www.cottongen.org/","linkVariable":""},{"value":"gromphadorhina portentosa","label":"Gromphadorhina portentosa","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"gryllodes sigillatus","label":"Gryllodes sigillatus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"haliotis rufescens","label":"Haliotis rufescens","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"hepacivirus hominis","label":"Hepatitis C Virus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"herpes simplex virus type 1","label":"Herpes simplex virus type 1","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"human","label":"Human","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"human coronavirus oc43","label":"Human coronavirus OC43","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"hydra vulgaris","label":"Hydra vulgaris","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"hydropsyche sp","label":"Hydropsyche sp","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"hymenoptera","label":"Hymenoptera","imageSrc":"","imageAlt":"","mod":"Hymenoptera Genome Database","modLink":"https://hymenoptera.elsiklab.missouri.edu/","linkVariable":""},{"value":"hypochaeris radicata","label":"Hypochaeris radicata","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"hypodynerus vespiformis","label":"Hypodynerus vespiformis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"iflaviridae","label":"Iflaviridae","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"iflavuris","label":"Iflavirus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ipomoea hederacea","label":"Ipomoea hederacea","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ischnomera","label":"Ischnomera","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ischnomera ruficollis","label":"Ischnomera ruficollis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"julidochromis marlieri","label":"Julidochromis marlieri","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"juniperus virginiana","label":"Juniperus virginiana","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"kluyveromyces marxianus","label":"Kluyveromyces marxianus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"l. casei","label":"L. casei","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"lacticaseibacillus casei","label":"Lacticaseibacillus casei","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"lactobacillus","label":"Lactobacillus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"larentiinae sp","label":"Larentiinae sp","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"laurus nobilis","label":"Laurus nobilis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"lepidoptera","label":"Lepidoptera","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"leucanthemum vulgare","label":"Leucanthemum vulgare","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ligilactobacillus","label":"Ligilactobacillus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ligilactobacillus salivarius","label":"Ligilactobacillus salivarius","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"limosilactobacillus","label":"Limosilactobacillus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"linepithema humile","label":"Linepithema humile","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"liometopum occidentale","label":"Liometopum occidentale","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"lolium arundinaceum","label":"Lolium arundinaceum","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"lontra longicaudis","label":"Lontra longicaudis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"lumbriculus variegatus","label":"Lumbriculus variegatus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"lumbricus terrestris","label":"Lumbricus terrestris","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"lupinus polyphyllus","label":"Lupinus polyphyllus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"lycorma delicatula","label":"Lycorma delicatula","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"lynx rufus","label":"Lynx rufus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"magnaporthe oryzae","label":"Magnaporthe oryzae","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"mammalia","label":"Mammalia","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"manihot esculenta","label":"Manihot esculenta","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"medicago lupulina","label":"Medicago lupulina","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"meloidogyne","label":"Meloidogyne","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"mimus polyglottos","label":"Mimus polyglottos","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"bryophyta","label":"Mosses","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"mouse","label":"Mouse","imageSrc":"","imageAlt":"","mod":"MGI","modLink":"https://informatics.jax.org","linkVariable":""},{"value":"m. minutoides","label":"Mus minutoides","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"mycobacterium smegmatis","label":"Mycobacterium smegmatis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"nakaseomyces glabratus","label":"Nakaseomyces glabratus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"nauphoeta cinerea","label":"Nauphoeta cinerea","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"neurospora","label":"Neurospora","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"n. benthamiana","label":"Nicotiana benthamiana","imageSrc":"","imageAlt":"","mod":"Solgenomics Network","modLink":"https://solgenomics.net/organism/Nicotiana_benthamiana/genome","linkVariable":""},{"value":"nicotiana tabacum","label":"Nicotiana tabacum","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"noctuidae","label":"Noctuidae","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"noctuidae sp","label":"Noctuidae sp","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"nothobranchius furzeri","label":"Nothobranchius furzeri","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"onchocerca volvulus","label":"Onchocerca volvulus","imageSrc":"","imageAlt":"","mod":"WormBase","modLink":"www.wormbase.org","linkVariable":""},{"value":"orconectes virilis","label":"Orconectes virilis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ormia ochracea","label":"Ormia ochracea","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"o. sativa","label":"Oryza sativa","imageSrc":"","imageAlt":"","mod":"Gramene","modLink":"https://www.gramene.org/","linkVariable":""},{"value":"other","label":"Other","imageSrc":"","imageAlt":"","mod":null,"modLink":null,"linkVariable":null},{"value":"oxalis enneaphylla","label":"Oxalis enneaphylla","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"paenarthrobacter nicotinovorans","label":"Paenarthrobacter nicotinovorans","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"paenarthrobacter nicotinovorans","label":"Paenarthrobacter nicotinovorans","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pantoea","label":"Pantoea","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pantoea agglomerans","label":"Pantoea agglomerans","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"papaver sp","label":"Papaver sp","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"paramecium bursaria","label":"Paramecium bursaria","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"partitiviridae","label":"Partitiviridae","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pelodiscus sinensis","label":"Pelodiscus sinensis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"perezia recurvata","label":"Perezia recurvata","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"petromyzon marinus","label":"Petromyzon marinus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"photinus pyralis","label":"Photinus pyralis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"photinus pyralis associated partiti-like virus","label":"Photinus pyralis associated partiti-like virus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"photinus pyralis iflavirus 1","label":"Photinus pyralis iflavirus 1","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"physcomitrium patens","label":"Physcomitrium patens","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pinus strobus","label":"Pinus strobus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pinus taeda","label":"Pinus taeda","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"platycheirus","label":"Platycheirus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"plectus sambesii","label":"Plectus sambesii","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pogonomyrmex occidentalis","label":"Pogonomyrmex occidentalis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"poncirus trifoliata","label":"Poncirus trifoliata","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"populus deltoides","label":"Populus deltoides","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"potato virus y","label":"Potato virus Y","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"primula magellanica","label":"Primula magellanica","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pristionchus pacificus","label":"Pristionchus pacificus","imageSrc":"","imageAlt":"","mod":"WormBase","modLink":"www.wormbase.org","linkVariable":""},{"value":"prunus persica","label":"Prunus persica","imageSrc":"","imageAlt":"","mod":"Genome Database for Rosaceae","modLink":"https://www.rosaceae.org/","linkVariable":""},{"value":"psalmopoeus iriminia","label":"Psalmopoeus iriminia","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pseudanabaena sp.","label":"Pseudanabaena sp.","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pseudomonas","label":"Pseudomonas","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pseudomonas aeruginosa","label":"Pseudomonas aeruginosa","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pseudomonas glycinae","label":"Pseudomonas glycinae","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pseudomonas putida","label":"Pseudomonas putida","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pseudomonas syringae","label":"Pseudomonas syringae","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"pterophyllum scalare","label":"Pterophyllum scalare","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"python regius","label":"Python regius","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"quercus macrocarpa","label":"Quercus macrocarpa","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ralstonia solanacearum","label":"Ralstonia solanacearum","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ranitomeya imitator","label":"Ranitomeya imitator","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ranunculus peduncularis","label":"Ranunculus peduncularis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"rat","label":"Rat","imageSrc":"","imageAlt":"","mod":"RGD","modLink":"https://rgd.mcw.edu","linkVariable":""},{"value":"rheinheimera","label":"Rheinheimera","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ribes rubrum","label":"Ribes rubrum","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"sars-cov-2","label":"SARS-CoV-2","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"s. cerevisiae","label":"Saccharomyces cerevisiae","imageSrc":"yeast.png","imageAlt":"Yeast graphic by Zoe Zorn CC BY 4.0","mod":"SGD","modLink":"https://yeastgenome.org","linkVariable":""},{"value":"saccharomyces paradoxus","label":"Saccharomyces paradoxus ","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"s. uvarum","label":"Saccharomyces uvarum","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"schistosoma","label":"Schistosoma","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"schizosaccharomyces japonicus","label":"Schizosaccharomyces japonicus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"s. pombe","label":"Schizosaccharomyces pombe","imageSrc":"pombe.png","imageAlt":"Pombe graphic by Zoe Zorn © Caltech","mod":"PomBase","modLink":"https://www.pombase.org/reference/PMID:","linkVariable":"pmId"},{"value":"schmidtea mediterranea","label":"Schmidtea mediterranea","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"senecio sp","label":"Senecio sp","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"simocephalus","label":"Simocephalus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"siraitia grosvenorii","label":"Siraitia grosvenorii","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"solanum lycopersicum","label":"Solanum lycopersicum","imageSrc":"","imageAlt":"","mod":"Solgenomics Network","modLink":"https://solgenomics.net/organism/1/view/","linkVariable":""},{"value":"sorghum","label":"Sorghum","imageSrc":"","imageAlt":"","mod":"SorghumBase","modLink":"https://www.sorghumbase.org","linkVariable":""},{"value":"spiroplasma eriocheiris","label":"Spiroplasma eriocheiris","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"staphylococcus aureus","label":"Staphylococcus aureus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"staphylococcus epidermidis","label":"Staphylococcus epidermidis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"steinernema carpocapsae","label":"Steinernema carpocapsae","imageSrc":"","imageAlt":"","mod":"WormBase","modLink":"https://wormbase.org","linkVariable":""},{"value":"steinernema hermaphroditum","label":"Steinernema hermaphroditum","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"stenotrophomonas geniculata","label":"Stenotrophomonas geniculata","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"stewartia floidana","label":"Stewartia floridana","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"streptococcus gordonii ","label":"Streptococcus gordonii ","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"streptococcus mutans","label":"Streptococcus mutans","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":" streptococcus pneumoniae","label":"Streptococcus pneumoniae","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"s. purpuratus","label":"Strongylocentrotus purpuratus","imageSrc":"","imageAlt":"","mod":"Echinobase","modLink":"https://www.echinobase.org","linkVariable":""},{"value":"strongyloides ratti","label":"Strongyloides ratti","imageSrc":"","imageAlt":"","mod":"WormBase","modLink":"www.wormbase.org","linkVariable":""},{"value":"sulfolobus","label":"Sulfolobus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"symphoricarpos albus","label":"Symphoricarpos albus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"syncirsodes","label":"Syncirsodes","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"synechococcus elongatus","label":"Synechococcus elongatus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"syrphidae","label":"Syrphidae","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"tarantobelus jeffdanielsi","label":"Tarantobelus jeffdanielsi","imageSrc":"","imageAlt":"","mod":"WormBase","modLink":"www.wormbase.org","linkVariable":""},{"value":"taraxacum officinale","label":"Taraxacum officinale","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"tatochila theodice","label":"Tatochila theodice","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"tetrahymena","label":"Tetrahymena","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"tetramorium immigrans","label":"Tetramorium immigrans","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"tomato brown rugose fruit virus","label":"ToBRFV","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"trachemys scripta","label":"Trachemys scripta","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"tribolium castaneum","label":"Tribolium castaneum","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"trichoptera","label":"Trichoptera","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"trichuris muris","label":"Trichuris muris","imageSrc":"","imageAlt":"","mod":"WormBase","modLink":"www.wormbase.org","linkVariable":""},{"value":"trifolium repens","label":"Trifolium repens","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"trypoxylus dichotomus","label":"Trypoxylus dichotomus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"tsuga canadensis","label":"Tsuga canadensis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"ulva expansa","label":"Ulva expansa","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"universal","label":"Universal","imageSrc":"","imageAlt":"","mod":null,"modLink":null,"linkVariable":null},{"value":"vargula hilgendorfii","label":"Vargula hilgendorfii","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"vespula vulgaris","label":"Vespula vulgaris","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"virus","label":"Virus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"watasenia scintillans","label":"Watasenia scintillans","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"wolbachia pipientis","label":"Wolbachia pipientis","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"xenopus","label":"Xenopus","imageSrc":"xenopus.png","imageAlt":"Xenopus graphic by Zoe Zorn CC BY 4.0","mod":"XenBase","modLink":"https://xenbase.org","linkVariable":""},{"value":"xenorhabdus griffiniae","label":"Xenorhabdus griffiniae","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"yramea cytheris","label":"Yramea cytheris","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"zaprionus indianus","label":"Zaprionus indianus","imageSrc":"","imageAlt":"","mod":"","modLink":"","linkVariable":""},{"value":"zea mays","label":"Zea mays","imageSrc":"","imageAlt":"","mod":"MaizeGDB","modLink":"https://www.maizegdb.org","linkVariable":""},{"value":"zebrafish","label":"Zebrafish","imageSrc":"zebrafish.png","imageAlt":"Zebrafish graphic by Zoe Zorn CC BY 4.0","mod":"ZFIN","modLink":"https://zfin.org","linkVariable":""}]}},"pageContext":{"id":"578fcdb4-5134-445e-8a62-7adf5dfbe939","citedBy":[],"parsedCsv":{"csvHeader":[],"csvData":[]}}},
    "staticQueryHashes": ["2114697108"]}